WO1999047679A2 - Genetic engineering salt tolerance in crop plants - Google Patents
Genetic engineering salt tolerance in crop plants Download PDFInfo
- Publication number
- WO1999047679A2 WO1999047679A2 PCT/CA1999/000219 CA9900219W WO9947679A2 WO 1999047679 A2 WO1999047679 A2 WO 1999047679A2 CA 9900219 W CA9900219 W CA 9900219W WO 9947679 A2 WO9947679 A2 WO 9947679A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- polypeptide
- acid molecule
- plant
- seq
- Prior art date
Links
- 230000015784 hyperosmotic salinity response Effects 0.000 title claims abstract description 116
- 244000038559 crop plants Species 0.000 title description 8
- 238000010353 genetic engineering Methods 0.000 title description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 403
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 395
- 229920001184 polypeptide Polymers 0.000 claims abstract description 390
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 369
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 365
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 365
- 210000004027 cell Anatomy 0.000 claims abstract description 221
- 230000001965 increasing effect Effects 0.000 claims abstract description 68
- 241000219195 Arabidopsis thaliana Species 0.000 claims abstract description 42
- 150000001768 cations Chemical class 0.000 claims abstract description 24
- 210000000172 cytosol Anatomy 0.000 claims abstract description 24
- 241000894007 species Species 0.000 claims abstract description 17
- 241000196324 Embryophyta Species 0.000 claims description 338
- 238000000034 method Methods 0.000 claims description 107
- 108010078791 Carrier Proteins Proteins 0.000 claims description 106
- 239000002773 nucleotide Substances 0.000 claims description 91
- 125000003729 nucleotide group Chemical group 0.000 claims description 91
- 150000001413 amino acids Chemical class 0.000 claims description 61
- 239000002299 complementary DNA Substances 0.000 claims description 59
- 230000009261 transgenic effect Effects 0.000 claims description 54
- 108090000623 proteins and genes Proteins 0.000 claims description 51
- 230000014509 gene expression Effects 0.000 claims description 49
- 239000013598 vector Substances 0.000 claims description 48
- 108091092194 transporter activity Proteins 0.000 claims description 47
- 102000040811 transporter activity Human genes 0.000 claims description 47
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 44
- 239000012634 fragment Substances 0.000 claims description 42
- 108020004414 DNA Proteins 0.000 claims description 38
- 210000001519 tissue Anatomy 0.000 claims description 30
- 238000009396 hybridization Methods 0.000 claims description 29
- 108091034117 Oligonucleotide Proteins 0.000 claims description 25
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 24
- 239000011734 sodium Substances 0.000 claims description 24
- 229910052708 sodium Inorganic materials 0.000 claims description 22
- 210000003934 vacuole Anatomy 0.000 claims description 16
- 240000007594 Oryza sativa Species 0.000 claims description 13
- 235000007164 Oryza sativa Nutrition 0.000 claims description 13
- 230000000295 complement effect Effects 0.000 claims description 13
- 235000009566 rice Nutrition 0.000 claims description 13
- 210000005253 yeast cell Anatomy 0.000 claims description 13
- 241000219305 Atriplex Species 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 241000219198 Brassica Species 0.000 claims description 10
- 102000053602 DNA Human genes 0.000 claims description 10
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 10
- 240000003768 Solanum lycopersicum Species 0.000 claims description 10
- 238000012258 culturing Methods 0.000 claims description 10
- 230000001939 inductive effect Effects 0.000 claims description 10
- 235000011331 Brassica Nutrition 0.000 claims description 9
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 9
- 230000001580 bacterial effect Effects 0.000 claims description 9
- 229920000742 Cotton Polymers 0.000 claims description 8
- 240000009088 Fragaria x ananassa Species 0.000 claims description 8
- 235000010469 Glycine max Nutrition 0.000 claims description 8
- 244000068988 Glycine max Species 0.000 claims description 8
- 240000005979 Hordeum vulgare Species 0.000 claims description 8
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 8
- 240000008415 Lactuca sativa Species 0.000 claims description 8
- 235000003228 Lactuca sativa Nutrition 0.000 claims description 8
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 8
- 244000061456 Solanum tuberosum Species 0.000 claims description 8
- 244000300264 Spinacia oleracea Species 0.000 claims description 8
- 235000009337 Spinacia oleracea Nutrition 0.000 claims description 8
- 235000021307 Triticum Nutrition 0.000 claims description 8
- 240000008042 Zea mays Species 0.000 claims description 8
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 8
- 238000010367 cloning Methods 0.000 claims description 8
- 235000005822 corn Nutrition 0.000 claims description 8
- 244000005700 microbiome Species 0.000 claims description 8
- 235000021012 strawberries Nutrition 0.000 claims description 8
- 230000001131 transforming effect Effects 0.000 claims description 8
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 7
- 210000001723 extracellular space Anatomy 0.000 claims description 7
- 241000201895 Salicornia Species 0.000 claims description 6
- 241000209056 Secale Species 0.000 claims description 6
- 235000007238 Secale cereale Nutrition 0.000 claims description 6
- -1 [SEQ ID NO:5] Chemical class 0.000 claims description 6
- 238000013518 transcription Methods 0.000 claims description 6
- 230000035897 transcription Effects 0.000 claims description 6
- 241000701489 Cauliflower mosaic virus Species 0.000 claims description 5
- 230000001172 regenerating effect Effects 0.000 claims description 5
- 108091033380 Coding strand Proteins 0.000 claims description 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 4
- 230000002538 fungal effect Effects 0.000 claims description 4
- 229910052744 lithium Inorganic materials 0.000 claims description 4
- 241000209510 Liliopsida Species 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 241001233957 eudicotyledons Species 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 240000004658 Medicago sativa Species 0.000 claims description 2
- 230000002194 synthesizing effect Effects 0.000 claims description 2
- 241000219146 Gossypium Species 0.000 claims 1
- 244000020551 Helianthus annuus Species 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 150000003839 salts Chemical class 0.000 abstract description 65
- 229910001415 sodium ion Inorganic materials 0.000 abstract description 39
- 230000012010 growth Effects 0.000 abstract description 16
- 239000002689 soil Substances 0.000 abstract description 16
- 238000001125 extrusion Methods 0.000 abstract description 8
- 229910001414 potassium ion Inorganic materials 0.000 abstract description 6
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 abstract description 5
- 229910001416 lithium ion Inorganic materials 0.000 abstract description 5
- 235000001014 amino acid Nutrition 0.000 description 60
- 229940024606 amino acid Drugs 0.000 description 57
- 241000219194 Arabidopsis Species 0.000 description 50
- 230000009466 transformation Effects 0.000 description 42
- 239000000523 sample Substances 0.000 description 37
- 230000002337 anti-port Effects 0.000 description 31
- 235000018102 proteins Nutrition 0.000 description 30
- 102000004169 proteins and genes Human genes 0.000 description 30
- 230000036961 partial effect Effects 0.000 description 29
- 238000003752 polymerase chain reaction Methods 0.000 description 27
- 230000000694 effects Effects 0.000 description 25
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 23
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 23
- 108010029485 Protein Isoforms Proteins 0.000 description 21
- 102000001708 Protein Isoforms Human genes 0.000 description 21
- 229930027917 kanamycin Natural products 0.000 description 21
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 21
- 229960000318 kanamycin Drugs 0.000 description 21
- 229930182823 kanamycin A Natural products 0.000 description 21
- 230000002018 overexpression Effects 0.000 description 20
- 239000002609 medium Substances 0.000 description 19
- 239000013615 primer Substances 0.000 description 19
- 230000000875 corresponding effect Effects 0.000 description 18
- 239000013604 expression vector Substances 0.000 description 18
- 239000000047 product Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 16
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 14
- 239000012528 membrane Substances 0.000 description 14
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 13
- 108020004635 Complementary DNA Proteins 0.000 description 13
- 108091028043 Nucleic acid sequence Proteins 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 13
- 241000589158 Agrobacterium Species 0.000 description 12
- 150000002500 ions Chemical class 0.000 description 12
- 230000001404 mediated effect Effects 0.000 description 12
- 108700026244 Open Reading Frames Proteins 0.000 description 11
- 239000002585 base Substances 0.000 description 11
- 239000011159 matrix material Substances 0.000 description 11
- 229920001817 Agar Polymers 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 230000032258 transport Effects 0.000 description 10
- 241000208818 Helianthus Species 0.000 description 9
- 230000000692 anti-sense effect Effects 0.000 description 9
- 239000001963 growth medium Substances 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 238000006467 substitution reaction Methods 0.000 description 9
- 238000002105 Southern blotting Methods 0.000 description 8
- 229930006000 Sucrose Natural products 0.000 description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
- 108700019146 Transgenes Proteins 0.000 description 8
- 238000003556 assay Methods 0.000 description 8
- 108020004999 messenger RNA Proteins 0.000 description 8
- 230000008929 regeneration Effects 0.000 description 8
- 238000011069 regeneration method Methods 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 239000005720 sucrose Substances 0.000 description 8
- 108091026890 Coding region Proteins 0.000 description 7
- 108020004705 Codon Proteins 0.000 description 7
- 244000299507 Gossypium hirsutum Species 0.000 description 7
- 241000238631 Hexapoda Species 0.000 description 7
- 241000209140 Triticum Species 0.000 description 7
- XSDQTOBWRPYKKA-UHFFFAOYSA-N amiloride Chemical compound NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N XSDQTOBWRPYKKA-UHFFFAOYSA-N 0.000 description 7
- 229960002576 amiloride Drugs 0.000 description 7
- 230000003321 amplification Effects 0.000 description 7
- 238000012512 characterization method Methods 0.000 description 7
- 238000007667 floating Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 229910052902 vermiculite Inorganic materials 0.000 description 7
- 239000010455 vermiculite Substances 0.000 description 7
- 235000019354 vermiculite Nutrition 0.000 description 7
- 241000335053 Beta vulgaris Species 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 210000000170 cell membrane Anatomy 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000219823 Medicago Species 0.000 description 5
- 238000000636 Northern blotting Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 108020001507 fusion proteins Proteins 0.000 description 5
- 102000037865 fusion proteins Human genes 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000001262 western blot Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 235000016068 Berberis vulgaris Nutrition 0.000 description 4
- 239000002028 Biomass Substances 0.000 description 4
- 206010020649 Hyperkeratosis Diseases 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 241000220259 Raphanus Species 0.000 description 4
- 239000011543 agarose gel Substances 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 210000004899 c-terminal region Anatomy 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000008595 infiltration Effects 0.000 description 4
- 238000001764 infiltration Methods 0.000 description 4
- 238000003973 irrigation Methods 0.000 description 4
- 230000002262 irrigation Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 239000006152 selective media Substances 0.000 description 4
- 230000009758 senescence Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 230000005026 transcription initiation Effects 0.000 description 4
- 241000701447 unidentified baculovirus Species 0.000 description 4
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 3
- 244000241257 Cucumis melo Species 0.000 description 3
- 240000008067 Cucumis sativus Species 0.000 description 3
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 3
- 239000003155 DNA primer Substances 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 244000061176 Nicotiana tabacum Species 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000021536 Sugar beet Nutrition 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 125000001165 hydrophobic group Chemical group 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002751 oligonucleotide probe Substances 0.000 description 3
- 235000019157 thiamine Nutrition 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- 239000011721 thiamine Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000007279 water homeostasis Effects 0.000 description 3
- 241000208140 Acer Species 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 235000021533 Beta vulgaris Nutrition 0.000 description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 description 2
- 240000001980 Cucurbita pepo Species 0.000 description 2
- 235000009852 Cucurbita pepo Nutrition 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- 235000009355 Dianthus caryophyllus Nutrition 0.000 description 2
- 240000006497 Dianthus caryophyllus Species 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 235000008694 Humulus lupulus Nutrition 0.000 description 2
- 244000025221 Humulus lupulus Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 102000007079 Peptide Fragments Human genes 0.000 description 2
- 108010033276 Peptide Fragments Proteins 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 240000004713 Pisum sativum Species 0.000 description 2
- 235000010582 Pisum sativum Nutrition 0.000 description 2
- 108010064851 Plant Proteins Proteins 0.000 description 2
- 241000219000 Populus Species 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 2
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 2
- 108091036066 Three prime untranslated region Proteins 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 101150103518 bar gene Proteins 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 235000001046 cacaotero Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000021186 dishes Nutrition 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000010230 functional analysis Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 2
- 229960000907 methylthioninium chloride Drugs 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 230000008635 plant growth Effects 0.000 description 2
- 235000021118 plant-derived protein Nutrition 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 108020004418 ribosomal RNA Proteins 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 235000020354 squash Nutrition 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 2
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- CZJZYCFVITYHDO-UHFFFAOYSA-N 3-benzyl-7H-purin-6-imine Chemical compound N=c1ncn(Cc2ccccc2)c2nc[nH]c12 CZJZYCFVITYHDO-UHFFFAOYSA-N 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 102100039338 Aminomethyltransferase, mitochondrial Human genes 0.000 description 1
- 108050001492 Ammonium transporters Proteins 0.000 description 1
- 229930183010 Amphotericin Natural products 0.000 description 1
- QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 108090000084 Antiporters Proteins 0.000 description 1
- 102000003669 Antiporters Human genes 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 108010023063 Bacto-peptone Proteins 0.000 description 1
- 235000021537 Beetroot Nutrition 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 235000009842 Cucumis melo Nutrition 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- 150000008574 D-amino acids Chemical class 0.000 description 1
- 108020001019 DNA Primers Proteins 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 108010074122 Ferredoxins Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 235000016462 Mimosa pudica Nutrition 0.000 description 1
- 240000001140 Mimosa pudica Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 101710172108 Na(+)/H(+) antiporter NhaC Proteins 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 101100533818 Onchocerca volvulus sod-4 gene Proteins 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 102000009609 Pyrophosphatases Human genes 0.000 description 1
- 108010009413 Pyrophosphatases Proteins 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 244000305267 Quercus macrolepis Species 0.000 description 1
- 235000016976 Quercus macrolepis Nutrition 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 108091027981 Response element Proteins 0.000 description 1
- 240000000528 Ricinus communis Species 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 108010085012 Steroid Receptors Proteins 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- 101000865057 Thermococcus litoralis DNA polymerase Proteins 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 239000000999 acridine dye Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940009444 amphotericin Drugs 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000016520 artichoke thistle Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000008238 biochemical pathway Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 230000004186 co-expression Effects 0.000 description 1
- 238000000975 co-precipitation Methods 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 239000002361 compost Substances 0.000 description 1
- 230000006552 constitutive activation Effects 0.000 description 1
- 230000010154 cross-pollination Effects 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- VUSHQLWDOJFSGF-UHFFFAOYSA-L disodium 3-carboxy-3,5-dihydroxy-5-oxopentanoate chloride Chemical compound [Na+].[Na+].Cl.[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O VUSHQLWDOJFSGF-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000012869 germination medium Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000002169 hydrotherapy Methods 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 230000009618 hypocotyl growth Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000014726 immortalization of host cell Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000037427 ion transport Effects 0.000 description 1
- 239000003621 irrigation water Substances 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 101150066555 lacZ gene Proteins 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000004777 loss-of-function mutation Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000002887 multiple sequence alignment Methods 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 230000002786 root growth Effects 0.000 description 1
- 239000012882 rooting medium Substances 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000005562 seed maturation Effects 0.000 description 1
- 230000009919 sequestration Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 101150005399 sod2 gene Proteins 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 102000005969 steroid hormone receptors Human genes 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 description 1
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- 230000007723 transport mechanism Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000002424 x-ray crystallography Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 229940023877 zeatin Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8273—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for drought, cold, salt resistance
Definitions
- a single gene (sod2) coding for a Na + /H + antiport has been shown to confer sodium tolerance in fission yeast [11 ,12], although the role of this plasma membrane-bound protein appears to be only limited to yeast.
- One of the main disadvantages of using this gene for transformation of plants is associated with the typical problems encountered in heterologous gene expression, i.e. incorrect folding of the gene product, targeting of the protein to the target membrane and regulation of the protein function.
- Plants that tolerate and grow in saline environments have high intracellular salt levels.
- a major component of the osmotic adjustment in these cells is accomplished by ion uptake.
- the utilization of inorganic ions for osmotic adjustment suggests that salt- tolerant plants must be able to tolerate high levels of salts within their cells.
- enzymes extracted from these plants show high sensitivity to salt.
- the sensitivity of the cytosolic enzymes to salt would suggest that the maintenance of low cytosolic sodium concentration, either by compartmentation in cell organelles or by exclusion through the plasma membrane, must be necessary if the enzymes in the cell are to be protected from the inimical effects of salt.
- Plant cells are structurally well suited to the compartmentation of ions. Large membrane-bound vacuoles are the site for a considerable amount of sequestration of ions and other osmotically active substances.
- a comparison of ion distribution in cells and tissues of various plant species indicates that a primary characteristic of salt tolerant plants is their ability to exclude sodium out of the cell and to take up sodium and to sequester it in the cell vacuoles.
- Transport mechanisms could actively move ions into the vacuole, removing the potentially harmful ions from the cytosol.
- These ions in turn, could act as an osmoticum within the vacuole, which would then be responsible for maintaining water flow into the cell.
- both specific transport systems for sodium accumulation in the vacuole and sodium extrusion out of the cell are correlated with salt tolerance.
- nucleic acid molecules preferably genes
- Agrobacterium tumefaciens-mediated transformation or particle-bombardment-mediated transformation are useful for depending upon the plant species.
- the invention includes an isolated nucleic acid molecule encoding a PNHX transporter polypeptide, or a fragment of a polypeptide having Na + /H + transporter activity and capable of increasing salt tolerance in a cell.
- the invention also relates to an isolated nucleic acid molecule encoding a THX transporter polypeptide, PNHX transporter polypeptide, or a fragment of a polypeptide having Na7H + transporter activity and capable of increasing salt tolerance in a cell, comprising a nucleic acid molecule selected from the group consisting of: (a) a nucleic acid molecule that hybridizes to all or part of a nucleic molecule in [SEQ ID NO:1], [SEQ ID NO:3], [SEQ ID NO:17], [SEQ ID NO:19], or a complement thereof under moderate or high stringency hybridization conditions, wherein the nucleic acid molecule encodes a TNHX transporter polypeptide, a PNHX transporter polypeptide or a polypeptide having Na7H + transporter activity and capable of increasing salt tolerance in a cell;
- nucleic acid molecule degenerate with respect to (a), wherein the nucleic molecule encodes a TNHX transporter polypeptide, a PNHX transporter polypeptide or a polypeptide having Na7H + transporter activity and capable of increasing salt tolerance in a cell.
- the hybridization conditions preferably comprise moderate (also called intermediate) or high stringency conditions selected from the conditions in Table 4.
- the invention also includes an isolated nucleic acid molecule encoding a THX transporter polypeptide or a PNHX transporter polypeptide, or a fragment of a polypeptide having Na + /H + transporter activity and capable of increasing salt tolerances in a cell, comprising a nucleic acid molecule selected from the group consisting of:
- nucleic acid molecule having at least 17% identity with the nucleotide sequence of (a) and which encodes a THX transporter polypeptide or the PNHX transporter polypeptide or a polypeptide having Na + /H + transporter activity.
- the THX transporter polypeptide or the PNHX transporter polypeptide preferably comprises an AtNHX transporter polypeptide having Na + /H + transporter activity and capable of increasing salt tolerance in a cell.
- the nucleic acid molecule may comprise all or part of a nucleotide sequence in [SEQ ID NO:1], [SEQ ID NO:3], [SEQ ID NO: 17] or [SEQ ID NO: 19] (or the coding region therof).
- the invention also includes an AtNHX nucleic acid molecule isolated from Arabidopsis thaliana, or a fragment thereof encoding a transporter polypeptide having Na7H + transporter activity and capable of increasing salt tolerance in a cell.
- Another aspect of the invention relates to a recombinant nucleic acid molecule comprising a nucleic acid molecule and a constitutive promoter sequence or an inducible promoter sequence, operatively linked so that the promoter enhances transcription of the nucleic acid molecule in a host cell.
- the nucleic acid molecule preferably comprises genomic DNA, cDNA or RNA. In another aspect, the nucleic acid molecule is chemically synthesized. The nucleic acid molecule is preferably isolated from Arabidopsis thaliana.
- the nucleic acid molecule preferably encodes a TNHX transporter polypeptide or PNHX transporter polypeptide that is capable of extruding monovalent cations out of the cytosol of a cell to provide the cell with increased salt tolerance, wherein the monovalent cations are selected from at least one of the group consisting of sodium, lithium and potassium.
- the cell preferably comprises a plant cell.
- the monovalent cations are preferably extruded into a vacuole or into the extracellular space.
- the invention also includes an isolated nucleic acid molecule comprising a nucleic acid molecule selected from the group consisting of 8 to 10 nucleotides of the nucleic acid molecules described above, 11 to 25 nucleotides of the nucleic acid molecules described above, and 26 to 50 nucleotides of the nucleic acid molecules described above.
- the invention also includes an isolated oligonucleotide comprising at least about 10 nucleotides from a sequence selected from the group consisting of 5'- GCCATGTTGGATTCTCTAGTGTCG-3 [SEQ ID NO:11], 5'- CCGAATTCTCAAAGCTTTTCTTCCACG-3' [SEQ ID NO: 12], 5'-
- the vector preferably comprises a promoter selected from the group consisting of a super promoter, a 35S promoter of cauliflower mosaic virus, a drought-inducible promoter, an ABA-inducible promoter, a heat shock-inducible promoter, a salt-inducible promoter, a copper-inducible promoter, a steroid-inducible promoter and a tissue-specific promoter.
- a promoter selected from the group consisting of a super promoter, a 35S promoter of cauliflower mosaic virus, a drought-inducible promoter, an ABA-inducible promoter, a heat shock-inducible promoter, a salt-inducible promoter, a copper-inducible promoter, a steroid-inducible promoter and a tissue-specific promoter.
- the invention also includes a host cell comprising a recombinant nucleic acid molecule of the invention, or progeny of the host cell.
- the host cell is preferably selected from the group consisting of a fungal cell, a yeast cell, a bacterial cell, a microorganism cell and a plant cell.
- the plant, a plant part, a seed, a plant cell or progeny thereof preferably comprises the recombinant nucleic acid molecule of the invention.
- the plant part preferably comprises all or part of a leaf, a flower, a stem, a root or a tuber.
- the plant, plant part, seed or plant cell is preferably of a species selected from the group consisting of potato, tomato, brassica, cotton, sunflower, strawberries, spinach, lettuce, rice, soybean, corn, wheat, rye, barley, atriplex, sorgum, alfalfa, salicornia and the plant species or types in Table 5.
- the plant, plant part, seed or plant cell preferably comprises a dicot plant or a monocot plant.
- the invention also relates to a method for producing a recombinant host cell capable of expressing the nucleic acid molecule of the invention, the method comprising introducing into the host cell a vector of the invention.
- the invention also includes a method of producing a genetically transformed plant which expresses TNHX or PNHX transporter polypeptide, comprising regenerating a genetically transformed plant from a plant cell, seed or plant part of the invention.
- the genome of the host cell also includes a functional TNHX or PNHX gene.
- the genome of the host cell does not include a functional TNHX or PNHX gene.
- the invention also includes a transgenic plant produced according to a method of the invention.
- Another aspect of the invention relates to a method for expressing a TNHX or PNHX transporter polypeptide in the host cell of the invention, a the plant, plant part, seed or plant cell of the invention, the method comprising culturing the host cell under conditions suitable for gene expression.
- a method for producing a transgenic plant that expresses elevated levels of PNHX transporter polypeptide relative to a non-transgenic plant comprising transforming a plant with the vector of the invention.
- the invention also relates to an isolated polypeptide encoded by and/or produced from a nucleic acid molecule of the invention, or the vector of the invention.
- the invention also relates to an isolated PNHX transporter polypeptide or a fragment thereof having Na7H + transporter activity and capable of increasing salt tolerance in a cell.
- the polypeptide of the invention preferably comprises an AtNHX transporter polypeptide.
- the polypeptide of the invention preferably comprises all or part of an amino acid sequence in [SEQ ID NOS: 2, 4, 6, 8, 18, or 20] (figure 1).
- the invention also includes a polypeptide fragment of the AtNHX transporter polypeptide of the invention, or a peptide mimetic of the AtNHX transporter polypeptide, having Na7H + transporter activity and capable of increasing salt tolerance in a cell.
- the polypeptide fragment of the invention preferably consists of at least 20 amino acids, which fragment has Na7H + transporter activity and is capable of increasing salt tolerance in a cell.
- the fragment or peptide mimetic of the invention is preferably capable of being bound by an antibody to a polypeptide of the invention.
- the polypeptide of the invention is recombinantly produced.
- the invention also includes an isolated and purified transporter polypeptide comprising the amino acid sequence of a TNHX transporter polypeptide or a PNHX transporter polypeptide, wherein the transporter polypeptide is encoded by a nucleic acid molecule that hybridizes under moderate or stringent conditions to a nucleic acid molecule in [SEQ ID NOS: 1 , 3, 5, 7, 17, or 19] (figure 1), a degenerate form thereof or a complement.
- the invention also includes a polypeptide comprising a sequence having greater than 28% sequence identity to a polypeptide of the invention (preferably a polypeptide in figure 1 , such as [SEQ ID NOS: 2, 4, 6, 8, 18, or 20]).
- the polypeptide of the invention preferably comprises a Na7H + transporter polypeptide.
- the polypeptide is preferably isolated from Arabidopsis thaliana.
- the invention also includes an isolated nucleic acid molecule encoding polypeptide of the invention (preferably a polypeptide in figure 1 : [SEQ ID NOS: 2, 4, 6, 8, 18, or 20]).
- Another aspect of the invention relates to an antibody directed against a polypeptide of the invention.
- the antibody of the invention preferably comprises a monoclonal antibody or a polyclonal antibody.
- the invention also relates to an isolated nucleic acid molecule encoding a TNHX transporter polypeptide or a PNHX transporter polypeptide, or a fragment of a polypeptide having Na7H + transporter activity and capable of increasing salt tolerance in a cell, comprising a nucleic acid molecule selected from the group consisting of:
- nucleic acid molecule that hybridizes to all or part of a nucleic molecule in [SEQ ID NO:5], [SEQ ID NO:7], [SEQ ID NO:9] or to a nucleic acid molecule comprising about nucleotides 1-1487 of [SEQ ID NO:9], or a complement thereof under moderate or high stringency hybridization conditions, wherein the nucleic acid molecule encodes a TNHX transporter polypeptide, a PNHX transporter polypeptide or a polypeptide having Na7H + transporter activity and capable of increasing salt tolerance in a cell; (b) a nucleic acid molecule degenerate with respect to (a), wherein the nucleic molecule encodes a TNHX polypeptide, a PNHX polypeptide or a polypeptide having Na7H + transporter activity and capable of increasing salt tolerance in a cell.
- nucleic acid molecule having at least 17% sequence identity with the nucleotide sequence of (c) and which encodes a TNHX transporter polypeptide, a PNHX transporter polypeptide or a polypeptide having Na + /H + transporter activity and capable of increasing salt tolerance in a cell.
- the invention also includes a polypeptide produced from a nucleic acid molecule of the invention.
- the invention includes a polypeptide comprising (a) the amino acid sequence in [SEQ ID NO:6], [SEQ ID NO:8], [SEQ ID NO: 10]; (b) amino acids 1 to 496 of [SEQ ID NO: 10]; and (c) a sequence having greater than 28% homology to the polypeptide in (a) or (b).
- the invention includes a polypeptide comprising a Na7H + transporter polypeptide capable of increasing salt tolerance in a cell.
- the invention also includes a DNA molecule encoding the polypeptides of the invention.
- the invention relates to a method of producing a genetically transformed plant which expresses or overexpresses a TNHX transporter polypeptide, a PNHX transporter polypeptide or a polypeptide having Na7H + transporter activity and capable of increasing salt tolerance in a cell and wherein the plant has increased salt tolerance, comprising: a) cloning or synthesizing a TNHX nucleic acid molecule, a PNHX nucleic acid molecule or a nucleic acid molecule which codes for a Na7H + transporter polypeptide, wherein the polypeptide is capable of providing salt tolerance to a plant; b) inserting the nucleic acid molecule in a vector so that the nucleic acid molecule is operably linked to a promoter; c) inserting the vector into a plant cell or plant seed; d) regenerating the plant from the plant cell or plant seed, wherein salt tolerance in the plant is increased compared to a wild type plant.
- the invention includes a transgenic plant produced according to a method of the invention.
- the nucleic acid molecules have several uses which will be discussed in more detail below.
- the nucleic acid molecules and the polypeptides are used in a method for protecting a plant from the adverse affects of a saline environment by incorporating a nucleic acid molecule for salt tolerance and/or the polypeptide of the invention into a plant.
- the nucleic acid molecules of the invention are also useful for the identification of homologous nucleic acid molecules from plant species, preferably salt tolerant species and genetically engineering salt tolerant plants of agricultural and commercial interest.
- the invention relates to isolated nucleic acid molecules encoding a polypeptide for extrusion of sodium ions from the cytosol of a cell to provide the cell with salt tolerance.
- the nucleic acid molecules preferably comprise the nucleotide sequence in figure 1(a) or (b).
- the nucleic acid molecules may be DNA or RNA.
- the nucleic acid molecules may be used to transform a cell selected from the group consisting of a plant cell, a yeast cell and a bacterial cell.
- the sodium ions are extruded into a vacuole or out of the cell.
- the nucleic acid molecules encode a Na7H + exchanger polypeptide.
- nucleic acid molecules are isolated from Arabidopsis thaliana.
- the invention includes an isolated nucleic acid molecule, comprising the DNA sequence in figure 1(a), (b), (c)(i), (c)(ii), (d) or (e).
- the invention also relates to an isolated nucleic acid molecule, comprising a sequence having greater than 17% homology to the sequences of the invention described in the preceding paragraphs.
- the nucleic acid molecule consists of a sequence selected from the group consisting of 8 to 10 nucleotides of the nucleic acid molecules of the invention, 11 to 25 nucleotides of the nucleic acid molecule and 26 to 50 nucleotides of the nucleic acid molecules. These nucleic acid molecules hybridize to nucleic acid molecules described in the preceding paragraphs.
- the nucleic acid molecule of the invention may have a sense or an antisense sequence.
- the invention is an isolated oligonucleotide consisting of a sequence selected from the group consisting of 5'- GCCATGTTGGATTCTCTAGTGTCG-3 [SEQ ID NO: 11], 5'- CCGAATTCTCAAAGCTTTTCTTCCACG-3' [SEQ ID NO: 12], 5'- CGGAATTCACAGAAAAACACAGTGAGGAT-3' [SEQ ID NO: 13], an oligonucleotide with an antisense sequence of 5'-GCCATGTTGGATTCTCTAGTGTCG-3 [SEQ ID NO: 14], an oligonucleotide with an antisense sequence of 5'- CCGAATTCTCAAAGCTTTTCTTCCACG-3' [SEQ ID NO: 15] and an oligonucleotide with an antisense sequence of 5'-CGGAATTCACAGAAAAACACAGTGAGGAT-3' [SEQ ID NO
- the invention includes an isolated oligonucleotide consisting of 5 to 15 nucleotides of these oligonucleotides.
- the invention includes an isolated oligonucleotide consisting of a sequence homologous to the oligonucleotide of claim 15 or claim 16.
- the invention is an expression vector comprising a nucleic acid molecule of the invention.
- the expression vector preferably consists of a promoter selected from the group consisting of a super promoter, a 35S promoter of cauliflower mosaic virus, a drought-inducible promoter, an ABA-inducible promoter, a heat shock-inducible promoter, a salt-inducible promoter, a copper-inducible promoter, a steroid-inducible promoter and a tissue-specific promoter.
- the invention is a polypeptide produced from the nucleic acid molecules of the invention.
- the invention is also a polypeptide produced from the expression vector.
- the polypeptide is used for extrusion of sodium ions from the cytosol of a cell to provide the cell with salt tolerance.
- the polypeptide has the amino acid sequence in figure 1(a)-( ⁇ )-
- the polypeptides may be homologous to the polypeptide in figure 1 (a)- (e).
- the polypeptides comprise a sequence having greater than 28% homology to the polypeptide in figure 1(a)-(e).
- the polypeptides are Na7H + exchanger polypeptides.
- the polypeptides are preferably isolated from Arabidopsis thaliana.
- the invention includes peptides consisting of at least 5 amino acids of the polypeptides described in the preceding paragraphs. In another embodiment, the peptides consist of 41 to 75 amino acids of the polypeptides described in the preceding paragraphs.
- the invention also includes isolated nucleic acid molecules encoding the polypeptides of the invention.
- the isolated nucleic acid molecule preferably encodes the polypeptide of figure 1(a)-(e).
- the polypeptides of the invention that extrude sodium ions from the cytosol of a cell to provide the cell with salt tolerance preferably consist of an amiloride binding domain.
- the amiloride binding domain is between amino acids 82 to 90 in both AtNHXI and AtNHX2. in figure 1 (a)-(e) and between amino acids 58 to 66 in both AtNHX3 and AtNHX4 in figures (d) and (e).
- the invention also includes a monoclonal antibody or polyclonal antibody directed against a polypeptide of the invention.
- Another embodiment of the invention includes a transformed microorganism comprising an isolated nucleic acid molecule of the invention.
- the invention also includes a transformed microorganism including an expression vector.
- the invention includes a plant cell transformed with a nucleic acid molecule of the invention.
- the invention also includes a yeast cell transformed with the nucleic acid molecule of the invention.
- the invention is a plant, plant part or seed, generated from a plant cell transformed with a nucleic acid molecule of the invention.
- the invention also relates to a plant, plant part, seed or plant cell transfected with a nucleic acid molecule of the invention.
- the plant, plant part, seed or plant cell is preferably selected from a species selected from the group consisting of potato, tomato, brassica, cotton, sunflower, strawberries, spinach, lettuce, rice, soybean, corn, wheat, rye, barley, atriplex, sorgum, alfalfa and salicornia and other plants in Table 5.
- the invention also includes a method for producing a polypeptide of the invention by culturing a plant, plant part, seed or plant cell of the invention and recovering the expressed polypeptide from the culture.
- the invention includes an isolated nucleic acid molecule encoding a polypeptide capable of extruding monovalent cations from the cytosol of a cell to provide the cell with increased salt tolerance.
- the nucleic acid molecule preferably includes the nucleotide sequence in figure 1 (a)-(e).
- the nucleic acid molecule is preferably DNA or RNA.
- the cell is preferably a plant cell, a yeast cell or a bacterial cell.
- the monovalent cations are preferably sodium, lithium or potassium.
- the monovalent cations are preferably extruded into a vacuole or out of the cell.
- the nucleic acid molecules preferably encode a Na7H + exchanger polypeptide.
- the nucleic acid molecule is preferably isolated from Arabidopsis thaliana.
- the invention also includes an isolated nucleic acid molecule, including a sequence having greater than 17% homology to a sequence referred to in the preceding paragraph.
- the invention also includes a nucleic acid molecule of 8 to 10 nucleotides, 11 to
- nucleic acid molecule of the invention 25 or 26 to 50 nucleotides of a nucleic acid molecule of the invention.
- the invention also includes a nucleic acid molecule which nucleic acid molecule hybridizes a nucleic acid molecule of the invention.
- the nucleic acid molecule comprises a sense or an antisense sequence.
- the invention also includes an isolated oligonucleotide including a sequence selected from the group consisting of 5'-GCCATGTTGGATTCTCTAGTGTCG-3 [SEQ ID NO:11], 5'- CCGAATTCTCAAAGCTTTTCTTCCACG-3' [SEQ ID NO:12], 5'- CGGAATTCACAGAAAAACACAGTGAGGAT-3' [SEQ ID NO: 13], 5'- GCCATGTTGGATTCTCTAGTGTCG-3 [SEQ ID NO:14], 5'- CCGAATTCTCAAAGCTTTTCTTCCACG-3' [SEQ ID NO: 15] and 5'-
- the invention also includes an isolated oligonucleotide having a sequence homologous to one of these oligonucleotides.
- the invention also includes an expression vector including a nucleic acid molecule of the invention.
- the expression vector preferably comprises a promoter selected from the group consisting of a super promoter, a 35S promoter of cauliflower mosaic virus, a drought-inducible promoter, an ABA-inducible promoter, a heat shock- inducible promoter, a salt-inducible promoter, a copper-inducible promoter, a steroid- inducible promoter and a tissue-specific promoter.
- the invention also includes a polypeptide produced from a nucleic acid molecule or expression vector of the invention.
- the invention also includes a polypeptide for extrusion of monovalent cations ions from the cytosol of a cell to provide the cell with salt tolerance.
- the invention also includes a polypeptide including the amino acid sequence in figure 1(a)-(e) or a polypeptide homologous to one of these sequences.
- the invention also includes a polypeptide including a sequence having greater than 28% homology to one of these polypeptides.
- the polypeptide is preferably a Na7H + exchanger polypeptide isolated from Arabidopsis thaliana.
- the invention also includes a peptide including at least 5 amino acids or 41 to 75 amino acids of the polypeptide of the invention.
- the invention also includes nucleic acid molecules these polypeptides.
- the invention includes a polypeptide for extrusion of monovalent cations ions from the cytosol of a cell to provide the cell with salt tolerance, including, but not necessarily having, an amiloride binding domain.
- Another aspect of the invention relates to a monoclonal or polyclonal antibody directed against a polypeptide of the invention.
- Another variation includes a transformed microorganism including an isolated nucleic acid molecule of the invention.
- the transformed microorganism preferably includes an expression vector of the invention.
- the plant, plant part, seed or plant cell is preferably from a species selected from the group consisting of potato, tomato, brassica, cotton, sunflower, strawberries, spinach, lettuce, rice, soybean, corn, wheat, rye, barley, atriplex, sorgum, alfalfa, salicornia and other plants in Table 5.
- the invention also includes a method for producing a peptide, by culturing the plant, plant part, seed or plant cell and recovering the expressed peptide from the culture.
- the invention includes a nucleic acid molecule that encodes all or part of a polypeptide capable of extruding monovalent cations from the cytosol of a cell to provide the cell with salt tolerance, wherein the sequence hybridizes to the nucleic acid molecule of all or part of [SEQ ID NO:1] or [SEQ ID NO:3], [SEQ ID NO:17], [SEQ ID NO: 19] , figure 5(b) or a nucleic acid molecule including nucleotides 1-1487 of figure 5(b) under low, medium and high stringency conditions.
- the high stringency conditions preferably comprise a wash stringency of selected from the group of hybridization and wash stringencies in Table 4.
- the invention includes an isolated nucleic acid molecule encoding a polypeptide capable of extruding monovalent cations from the cytosol of a cell to provide the cell with salt tolerance, including the nucleic acid molecule in figure 5(b).
- the invention also includes an isolated nucleic acid molecule encoding a polypeptide capable of extruding monovalent cations from the cytosol of a cell to provide the cell with salt tolerance, including nucleotides 1 to 1487 of the nucleic acid molecule in figure 5(b).
- nucleic acid molecule including about 1640 (or preferably about 1600 or 1700) nucleic acids encoding a polypeptide capable of extruding monovalent cations from the cytosol of a cell to provide the cell with salt tolerance, the nucleic acid molecule including nucleotides 1 to 1487 (or preferably about nucleotides 1 to 1470, 1480, 1490 or 1500) of the nucleic acid molecule in figure 5(b).
- the molecule is preferably DNA or RNA.
- the cell is preferably selected from the group consisting of a plant cell, a yeast cell and a bacterial cell.
- the molecule preferably encodes a Na7H + exchanger polypeptide.
- the nucleic acid molecule is preferably isolated from Arabidopsis thaliana.
- the invention also includes the nucleic acid molecule in figure 5(b) or a nucleic acid molecule having greater than 17% homology to the sequence in 5(b).
- the invention includes polypeptides produced from this one of these nucleic acid molecules.
- the invention also relates to a polypeptide including the amino acid sequence in figure 5(b) or amino acids 1 to 496 of figure 5(b). (note: polypeptide including 1 to 496 is preferably about 530, 540 or 550 amino acids, most preferably about 538 amino acids) or a homologous polypeptide, preferably having greater than 28% homology.
- the polypeptide is preferably a Na7H + exchanger polypeptide, isolated from Arabidopsis thaliana.
- the invention also includes a DNA molecule encoding one of these polypeptides.
- the invention includes an isolated nucleic acid molecule encoding a polypeptide capable of extruding monovalent cations from the cytosol of a cell to provide the cell with salt tolerance, including at least one of the nucleic acid molecules in figure 1(c).
- the molecule is preferably DNA or RNA.
- the cell is preferably selected from the group consisting of a plant cell, a yeast cell and a bacterial cell and encodes a Na7H + exchanger polypeptide isolated from Arabidopsis thaliana.
- the invention includes an isolated nucleic acid molecule, including the nucleic acid molecule in figure 1 (c)(i) or 1 (c)(ii) or a polypeptide produced from a nucleic acid molecule of the invention.
- the invention also includes a polypeptide including the amino acid sequence in figure 1(c)(i) or 1 (c)(ii) or homologous to this polypeptide, preferably having greater than 28% homology.
- the polypeptide is preferably a Na7H + exchanger polypeptide, isolated from Arabidopsis thaliana.
- the invention includes a DNA molecule encoding one of these polypeptides.
- sequences in figures 1 (c) and 5 are useful in isolating other salt tolerant nucleic acid molecules (for example probes may be made from the sequences in figures 1 (c) and 5), preparing transgenic plants and performing many of the other methods of the invention that are described with respect to sequences in figures 1(a), (b), (d) and (e).
- Variants and modifications of figure 1 (c) and figure 5 sequences are also included within the invention as are methods using varied or modified sequences (the same preferred percentages of identity and sequence described with respect to figures 1(a), (b), (d) and (e) also apply to figures 1(c) and 5).
- Nucleic acid molecules including a portion of the nucleic acid molecule in figure 5 preferably include about nucleotides 1-1487 (or a partial sequence thereof, preferably starting from the coding region, which will be apparent to a skilled person, at about nucleotide 286).
- the nucleotide sequence including all or part of sequence in figure 1(c) or figure (5) will be preferably about 1683 or about 1614 nucleotides in length, respectively, (or 1683 or 1614 nucleotides minus part or all of the 5' or 3' untranslated region nucleotides).
- the nucleic acid molecules are most preferably 1600 to 1620 or 1670 to 1690 nucleotides in length.
- Polypeptides including a portion of the nucleic acid molecule in figure 5 preferably include about amino acids 1 to 496 (or a partial sequence thereof) in figure 5.
- the sequences encoding all or part of the polypeptide in figure 5 or encoding a polypeptide corresponding to either of the nucleic acid molecule sequences in figure 1 (c) are preferably about 538 amino acids (preferably about 60 kda) and about 318 amino acids in length, respectively.
- Preferred polypeptides are about 530-550 amino acids in length or 310-330 amino acids.
- Polypeptides including a portion of the nucleic acid molecule in figure 1 (c) preferably include part or all of either of the sequences in 1 (c) (nucleic acid molecules preferably include all or part of the corresponding nucleic acid molecule sequences).
- Figure 1 Shows the nucleic acid molecule that is [SEQ ID NO:1] and the polypeptide that is [SEQ ID NO:2].
- the figure shows isolated AtNHXI cDNA encoding a Na7H + exchanger from Arabidopsis thaliana showing cDNA sequence and the corresponding amino acid sequence for AtNHXI . Twelve transmembrane domains are present, a conserved amiloride-binding domain is present, and a relatively hydrophilic C-terminal region is also present.
- the predicted open reading frame begins at nucleotide 286. The amino acids are centred below the corresponding codon and are numbered on the left;
- the figure shows isolated AtNHX2 cDNA encoding a Na7H + exchanger from Arabidopsis thaliana showing cDNA sequence and the corresponding predicted amino acid sequence for AtNHX2.
- the predicted open reading frame begins at nucleotide 61.
- the amino acids are centred below the corresponding codon and are numbered on the left;
- the figure shows AtNHX3 partial cDNA sequences.
- the amino acids are centred below the corresponding codon and are numbered on the left (i) 5' sequence of the partial AtNHX3 cDNA and amino acid sequence; (ii) In a preferred embodiment, the figure shows 3' sequence of the partial AtNHX3 cDNA and amino sequence;
- the figure shows isolated AtNHX3 cDNA encoding a Na7H + exchanger from Arabidopsis thaliana showing cDNA sequence and the corresponding predicted amino acid sequence for AtNHX3.
- the predicted open reading frame begins at nucleotide 67. The amino acids are centred below the corresponding codon and are numbered on the left, (e) Isolated AtNHX4 cDNA encoding a Na7H + exchanger from Arabidopsis thaliana showing cDNA sequence [SEQ ID NO: 19] and the corresponding predicted amino acid sequence [SEQ ID NO:20] for AtNHX4.
- the predicted open reading frame begins at nucleotide 55. The amino acids are centred below the corresponding codon and are numbered on the left.
- (e) Shows the nucleic acid molecule that is [SEQ ID NO: 19] and the polypeptide that is [SEQ ID NO:20].
- the figure shows isolated AtNHX4 cDNA encoding a
- FIG. 4 RNA blot of AtNHXI expression in different tissues.
- Total RNA 40 ⁇ g was separated on a 1.0% agarose gel, transferred to a GeneScreen Plus membrane (Amersham) and hybridized to a radiolabelled AtNHXI cDNA probe as described in Materials and Methods.
- Tissues in each lane were as follows: 1 , mature leaf; 2, flower (including sepals); 3, infloresence stem; 4, seedling shoot; 5, seedling root.
- Figure 5 (a) and (b) show the nucleic acid molecule that is [SEQ ID NO:9] and the polypeptide that is [SEQ ID NO: 10].
- (a) and (b) show modified arabidopsis sodium/proton antiporter cDNA and polypeptide sequence.
- Figure 6. RNA blot comparing transcript levels in Arabidopsis thaliana leaf tissue from wild type and different transgenic lines overexpressing AtNHXI. RNA was extracted from 4 week-old plants. Total RNA (30 ⁇ g per lane) was separated on a 1.0 % agarose gel, transferred to a GeneScreen Plus membrane (Amersham) and hybridized to a radiolabelled AtNHXI cDNA probe as described in Materials and Methods. An endogenous 2.1 kb transcript was detected in the transgenic lines as well as in wild type.
- FIG. 7 Twenty 3-week old kanamycin-resistant Arabidopsis thaliana plants for each of the 3 independent transgenic lines (X1.2' , X1.3' and X1.4') transformed with AtNHXI, as well as 20 wild-type plants of the same age were used for assessment of salt tolerance. Plants were watered with 25 ml of 1/8 strength MS salts (control solution) supplemented with different concentrations of NaCI.
- Figure 8. shows [SEQ ID NO:21]
- b shows [SEQ ID NO:22]
- c shows [SEQ ID NO:23]
- d shows [SEQ ID NO:24]
- e shows [SEQ ID NO:25]
- f shows [SEQ ID NO:26]
- g shows [SEQ ID NO:27]
- h shows [SEQ ID NO:28].
- (a)-(h) show sequences from Table 2: (a) GenBank Accession No. 3850064 569 a.a.; (b) GenBank Accession No. 927695 633 a.a.; (c) GenBank Accession No. C91832 378 bp mRNA EST; (d) GenBank Accession No. C91861 268 bp mRNA EST; (e) GenBank Accession No. AU032544 380 bp mRNA EST; (f) GenBank Accession No. AA660573 596 bp mRNA EST; (g) GenBank Accession No. L44032 522 bp mRNA STS; (h) GenBank Accession No. T75860 (EST) 330 bp mRNA EST.
- the invention relates to nucleic acid molecules and polypeptides which increase salt tolerance in cells and plants.
- PNHX polypeptides are plant Na7H + transporter polypeptides that are capable of increasing and enhancing salt tolerance in a cell, preferably a plant cell.
- These transporters also referred to as exchangers, antiports or antiporters
- extrude monovalent cations preferably potassium ions or lithium ions, most preferably sodium ions
- the cations are preferably extruded into the vacuoles or extracellular space.
- the affinity for particular ions varies between transporters.
- the listed preferences refer to the cations that are most likely to be abundant in the cytosol and therefore most likely to be extruded.
- the PNHX nucleic acid molecules which encode PNHX polypeptides are particularly useful in producing transgenic plants which have increased salt tolerance compared to a wild type plant. It will also be apparent that there are polypeptide and nucleic acid molecules from other organisms, such as yeast, microorganisms, fish, birds or mammals, that are similar to PNHX polypeptides and nucleic acid molecules.
- the entire group of Na7H + transporter polypeptides and nucleic acid molecules that are capable of increasing salt tolerance in a cell are collectively referred to as (“TNHX polypeptides" and "TNHX nucleic acid molecules").
- TNHX polypeptides are Na7H + transporters that are capable of increasing salt tolerance in a cell, preferably a plant cell, because they extrude monovalent cations (preferably potassium ions or lithium ions, most preferably sodium ions) out of the cytosol.
- monovalent cations preferably potassium ions or lithium ions, most preferably sodium ions
- TNHX and PNHX nucleic acid molecules and polypeptides in maintaining salt tolerance was not shown before this invention. The ability of these compounds to increase salt tolerance of transgenic host cells (particularly plant cells) and transgenic plants compared to wild type cells and plants was unknown. PNHX and TNHX polypeptides need not necessarily have the primary function of providing salt tolerance. All nucleotides and polypeptides which are suitable for use in the methods of the invention, such as the preparation of transgenic host cells or transgenic plants, are included within the scope of the invention. Genomic clones or cDNA clones are preferred for preparation of transgenic cells and plants. In a preferred embodiment, the invention relates to cDNAs encoding Na7H + exchangers from Arabidopsis thaliana.
- AtNHXI and AtNHX2 are homologs that are physically located at different places in the genome.
- the invention also includes splice variants of the nucleic acid molecules as well as polypeptides produced from the molecules.
- AtNHX3 and AtNHX4 are homologs of AtNHXI and AtNHX2.
- AtNHX3 and AtNHX4 are identical for a long sequence beginning at the N-terminus. This indicates that the difference in sequence at the C-terminus is due to alternative splicing of a nucleic acid molecule (also known as splicing variants). This allows a single nucleic acid molecule to produce varying polypeptides.
- the longest open reading frame of 1614 base pairs in AtNHXI encodes a polypeptide of 538 amino acids with a predicted molecular weight ("MW) of about 60 Kda.
- MW molecular weight
- This polypeptide encoded by the open reading frame was about 19% larger than the sequence predicted by the Arabidopsis genomic sequence (A_TM021 B04.4).
- This sequence encodes the full length exchanger given that the cDNA region immediately upstream of the start codon contains predicted stop codons in all three reading frames.
- AtNHXI a transcript of approximately 2 kb, which corresponds roughly in size to the predicted mRNA for AtNHXI , was observed on RNA blots. Based on the amino acid sequence of AtNHXI , 12 transmembrane domains are predicted, a conserved amiloride-binding domain is present, and a relatively hydrophilic C-terminal region is also predicted. AtNHXI shows some similarity at the amino acid level to Na7H + exchangers isolated from a variety of organisms ranging from yeast (about 27% identity) to humans (about 20%). A second salt tolerance cDNA and polypeptide, AtNHX2, was obtained from Arabidopsis thaliana ( Figure 1(b)).
- the invention includes DNA sequences (and the corresponding polypeptide) including at least one of the sequences shown in figure 1 (c) in a nucleic acid molecule of preferably about: less than 1000 base pairs, less than 1250 base pairs, less than 1500 base pairs, less than 1750 base pairs, less than 2000 base pairs, less than 2250 base pairs, less than 2500 base pairs, less than 2750 base pairs or less than 3000 base pairs.
- a nucleic acid molecule of preferably about: less than 1000 base pairs, less than 1250 base pairs, less than 1500 base pairs, less than 1750 base pairs, less than 2000 base pairs, less than 2250 base pairs, less than 2500 base pairs, less than 2750 base pairs or less than 3000 base pairs.
- a fourth sequence, AtNHX4 was also identified (figure 1(e)).
- the coding regions of the nucleic acid molecules are as follows:
- nucleic acid molecules sequence identity, hybridization and other aspects of nucleic acid molecules included within the scope of the invention is intended to be applicable to either the entire nucleic acid molecules in figures 1(a), (b), (d) and (e) and the coding regions of these molecules, shown in Table 1.
- Other possible modifications to the sequence will also be apparent.
- Southern Blot Analysis (figure 3) suggests that AtNHXI is likely present as a single copy gene in Arabidopsis.
- a Northern blot (figure 4) showed that AtNHX polypeptide (particularly AtNHXI) was expressed in all tissues examined (root, shoot (shoot includes leaves and stems), flower, inflorescence stem). Function of Salt Tolerance Nucleic Acid Molecules
- the polypeptides of the invention allow the extrusion of monovalent cations (preferably potassium ions or lithium ions, most preferably sodium ions) from the cytosol, which in this application preferably refers to the transport and accumulation of sodium ions into the vacuoles or into the extracellular space (outside of the cell), thus providing the most important trait for salt tolerance in plants.
- monovalent cations preferably potassium ions or lithium ions, most preferably sodium ions
- Antiport polypeptides from organisms other than plants have shown different specificity for monovalent ions (e.g. D.G. Warnock, A.S. Pollock, "Sodium Proton Exchange in Epithelial Cells", pages 77-90, in S. Grinstein ed.
- TNHX and PNHX transporters will also show different specificity between transporters.
- the nucleic acid molecules of the invention allow the engineering of salt tolerant plants by transformation of crops with this nucleic acid molecule under the control of constitutively active promoters or under the control of conditionally-inducible promoters. The resulting expression or overexpression of these nucleic acid molecules confers increased salt tolerance in plants grown in soil, solid, semi-solid medium or hydroponically.
- the PNHX Nucleic Acid Molecule and Polypeptide is conserveed in Plants
- PNHX nucleic acid molecules from plants having nucleic acid molecules that are similar to those in Arabidopsis thaliana, such as beet, tomato, rice, cucumber, radish and other plants as in Table 5 and using techniques described in this application.
- the invention includes methods of isolating these nucleic acid molecules and polypeptides as well as methods of using these nucleic acid molecules and polypeptides according to the methods described in this application, for example those used with respect to AtNHX.
- Table 2 below shows several sequences with sequence identity and sequence similarity to the AtNHX polypeptides. Where polypeptides are shown, a suitable corresponding DNA encoding the polypeptide will be apparent. These sequences code for polypeptides similar to portions of AtNHX polypeptides.
- the sequences in Table 2 are useful to make probes to identity full length sequences or fragments (from the listed species or other species).
- One skilled in the art would be able to design a probe based on a polypeptide or peptide fragment.
- the invention includes nucleic acid molecules of about: 10 to 50 nucleotides, 50 to 200 nucleotides, 200 to 500 nucleotides, 500 to 1000 nucleotides, 1000 to 1500 nucleotides, 1500 to 1700 nucleotides, 1700 to 2000 nucleotides, 2000 to 2500 nucleotides or at least 2500 nucleotides and which include all or part of the sequences (or corresponding nucleic acid molecule) in Table 2.
- the invention also includes peptides and polypeptides of about: 10 to 50 amino acids, 50 to 200 amino acids, 200 to 500 amino acids, 500 to 750 amino acids or at least 750 amino acids which encode all or part of the polypeptides in Table 2 (wherein the polypeptide is produced according to a reading frame aligned with an AtNHX polypeptide). Possible modifications to these sequences will also be apparent.
- the polypeptide and nucleic acid molecules are also useful in research experiments or in bioinformatics to locate other sequences.
- the nucleic acid molecules and polypeptides preferably provide Na7H + transporter activity and are capable of moving monovalent cations from the cytosol of the cell into vacuoles or the extracellular space (in this application, extracellular space refers to the space outside a cell in an organism or the space outside a cultured cell).
- nucleic acid molecules encoding the homologous polypeptide in other plant species will have DNA sequence identity (homology) at least about > 17%, >20%, >25%, >35% to a DNA sequence shown in figure 1 or 5 (or a partial sequence thereof).
- Some plants species may have DNA with a sequence identity (homology) at least about: >50%, >60%, >70%, >80% or >90% more preferably at least about >95%, >99% or >99.5%, to a DNA sequence in figure 1 or 5 (or a partial sequence thereof).
- the invention also includes modified nucleic acid molecules from plants other than Arabidopsis thaliana which have sequence identity at least about: > 17%, >20%, >25%, >35%, >50%, >60%, >70%, >80% or >90% more preferably at least about >95%, >99% or >99.5%, to an AtNHX sequence in figure 1 or 5 (or a partial sequence thereof). Modified nucleic acid molecules are discussed below.
- Sequence identity is most preferably calculated as the number of identical amino acid residues expressed as a percentage of the length of the shorter of the two sequences in a pairwise alignment.
- Sequence A For example, if a nucleotide sequence (called “Sequence A”) has 90% identity to a portion of the nucleotide sequence in Figure 1(a), then Sequence A will be identical to the referenced portion of the nucleotide sequence in Figure 8, except that Sequence A may include up to 10 point mutations, such as substitutions with other nucleotides, per each 100 nucleotides of the referenced portion of the nucleotide sequence in Figure 8. Polypeptides having sequence identity may be similarly identified.
- the invention also includes nucleic acid molecules encoding polypeptides having sequence similarity taking into account conservative amino acid substitutions. Sequence similarity (and preferred percentages) are discussed below.
- nucleic acid molecule encoding the homologous Na7H + exchanger in other species will hybridize to all or part of a sequence in figure 1 or 5 (or a partial sequence thereof) under low, moderate (also called intermediate conditions) or high stringency conditions. Preferred hybridization conditions are described below.
- the invention includes the nucleic acid molecules from other plants as well as methods of obtaining the nucleic acid molecules by, for example, screening a cDNA library or other DNA collection with a probe of the invention (such as a probe comprising at least about: 10 or preferably at least 15 or 30 nucleotides of AtNHXI , AtNHX2, AtNHX3 or AtNHX4 or a sequence in figure 5) and detecting the presence of a TNHX or PNHX nucleic acid molecule.
- Another method involves comparing the AtNHX sequences (eg in figure 1 or 5) to other sequences, for example using bioinformatics techniques such as database searches or alignment strategies, and detecting the presence of a TNHX or PNHX nucleic acid molecule or polypeptide.
- the invention includes the nucleic acid molecule and/or polypeptide obtained according to the methods of the invention.
- the invention also includes methods of using the nucleic acid molecules, for example to make probes, in research experiments or to transform host cells or make transgenic plants. These methods are as described below.
- sequence identity for sequences of the invention includes sequences having identity of at least about: 30% to AtNHXI , 31% to AtNHX2, 36% to AtNHX3, and 36% to AtNHX4. Sequence identity may be at least about: >20%, >25%, >28%, >30%, >35%, >40%, >50% to an amino acid sequence shown in figure 1 or 5 (or a partial sequence thereof).
- polypeptides may have a sequence identity of at least about: >60%, >70%, >80% or >90%, more preferably at least about: >95%, >99% or >99.5% to an amino acid sequence in figure 1 or 5 (or a partial sequence thereof). Identity is calculated according to methods known in the art. Sequence identity is most preferably assessed by the Clustal W program.
- the invention also includes modified polypeptides from plants which have sequence identity at least about: >20%, >25%, >28%, >30%, >35%, >40%, >50%, >60%, >70%, >80% or >90% more preferably at least about >95%, >99% or >99.5%, to an AtNHX sequence in figure 1 or 5 (or a partial sequence thereof). Modified polypeptides molecules are discussed below. Preferably about: 1 , 2, 3, 4, 5, 6 to 10, 10 to 25, 26 to 50 or 51 to 100, or 101 to 250 nucleotides or amino acids are modified. Table 3
- Plant Vacuolar H * -PPiase (vacuolar pyrophosphatase)
- Curcubita (Cucumber) (Accession # D45078) 66.5% 39.1%
- Raphanus (radish) (Accession # D84669) 56.7% 37.4%
- Helianthus (Accession # X95951 ) 50.4% 35.2%
- Arabidopsis (Accession # X75879) 100% 100%
- nucleic Acid Molecules and Polypeptides similar to AtNHX are not the only sequences which may be used to provide increased salt tolerance in plants.
- the genetic code is degenerate so other nucleic acid molecules which encode a polypeptide identical to an amino acid sequence in figure 1(a), (b), (d) or (e) may also be used.
- the sequence of the other nucleic acid molecules of this invention may also be varied without changing the polypeptide encoded by the sequence.
- nucleic acid molecule constructs described below and in the accompanying examples for the preferred nucleic acid molecules, vectors, and transformants of the invention are merely illustrative and are not intended to limit the scope of the invention.
- the sequences of the invention can be prepared according to numerous techniques. The invention is not limited to any particular preparation means.
- the nucleic acid molecules of the invention can be produced by cDNA cloning, genomic cloning, DNA synthesis, polymerase chain reaction (PCR) technology, or a combination of these approaches ([31] or Current Protocols in Molecular Biology (F. M. Ausbel et al., 1989).). Sequences may be synthesized using well known methods and equipment, such as automated synthesizers.
- Nucleic acid molecules may be amplified by the polymerase chain reaction. Polypeptides may, for example, be synthesized or produced recombinantly. Sequence Identity
- the invention includes modified nucleic acid molecules with a sequence identity at least about: >17%, >20%, >30%, >40%, >50%, >60%, >70%, >80% or >90% more preferably at least about >95%, >99% or >99.5%, to a DNA sequence in figure 1 or 5 (or a partial sequence thereof).
- a DNA sequence in figure 1 or 5 or a partial sequence thereof.
- Identity is calculated according to methods known in the art. Sequence identity is most preferably assessed by the Clustal W program.
- Sequence A For example, if a nucleotide sequence (called “Sequence A”) has 90% identity to a portion of the nucleotide sequence in Figure 1 (a), then Sequence A will be identical to the referenced portion of the nucleotide sequence in Figure 1 , except that Sequence A may include up to 10 point mutations, such as deletions or substitutions with other nucleotides, per each 100 nucleotide of the referenced portion of the nucleotide sequence in Figure 1. Nucleotide sequences functionally equivalent to the PNHX or AtNHX sequences can occur in a variety of forms as described below. Polypeptides having sequence identity may be similarly identified.
- polypeptides encoded by the homologous NHX, PNHX Na7H + exchange nucleic acid molecule in other species will have amino acid sequence identity (also known as homology) at least about: >20%, >25%, >28%, >30%, >40% or >50% to an amino acid sequence shown in figure 1 or 5 (or a partial sequence thereof).
- Some plants species may have polypeptides with a sequence identity (homology) of at least about: >60%, >70%, >80% or >90%, more preferably at least about: >95%, >99% or >99.5% to all or part of an amino acid sequence in figure 1 or 5 (or a partial sequence thereof).
- Identity is calculated according to methods known in the art. Sequence identity is most preferably assessed by the Clustal W program. Preferably about: 1 , 2, 3, 4, 5, 6 to 10, 10 to 25, 26 to 50 or 51 to 100, or 101 to 250 nucleotides or amino acids are modified.
- the invention includes nucleic acid molecules with mutations that cause an amino acid change in a portion of the polypeptide not involved in providing salt tolerance and ion transport or an amino acid change in a portion of the polypeptide involved in providing salt tolerance so that the mutation increases or decreases the activity of the polypeptide.
- AtNHX nucleic acid molecules encoding nucleic acids can be isolated using conventional DNA-DNA or DNA-RNA hybridization techniques. These nucleic acid molecules and the AtNHX sequences can be modified without significantly affecting their activity.
- the present invention also includes nucleic acid molecules that hybridize to one or more of the sequences in figure 1 or 5 (or a partial sequence thereof) or their complementary sequences, and that encode expression for peptides or polypeptides exhibiting substantially equivalent activity as that of an AtNHX polypeptide produced by the DNA in figure 1 or their variants.
- Such nucleic acid molecules preferably hybridize to the sequences under low, moderate (intermediate), or high stringency conditions, (see Sambrook et al. (Most recent edition) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.). Preferable hybridization conditions are about those in Table 4.
- the present invention also includes nucleic acid molecules from any source, whether modified or not, that hybridize to genomic DNA, cDNA, or synthetic DNA molecules that encode the amino acid sequence of an AtNHX polypeptide, or genetically degenerate forms, under salt and temperature conditions equivalent to those described in this application, and that code for a peptide, polypeptide or polypeptide that has Na7H + transporter activity.
- the polypeptide has the same or similar activity as that of an AtNHX polypeptide.
- the nucleic acid molecules may encode TNHX or PNHX polypeptides.
- a nucleic acid molecule described above is considered to be functionally equivalent to an AtNHX nucleic acid molecule (and thereby having Na7H + transporter activity) of the present invention if the polypeptide produced by the nucleic acid molecule displays the following characteristics: the polypeptide mediates the proton-dependent sodium transport and sodium-dependent proton transport in intact cells, isolated organelles and purified membrane vesicles. These sodium/proton movements should be higher (preferably at least about 50% higher and most preferably at least about 100% higher) than the proton movements observed in the presence of a background of potassium ions and/or other monovalent cations (i.e. rubidium, cesium, etc., but most preferably not lithium) (13,14).
- the invention also includes nucleic acid molecules and polypeptides having sequence similarity taking into account conservative amino acid substitutions. Sequence similarity (and preferred percentages) are discussed below. Modifications to Nucleic Acid Molecule or Polypeptide Sequence
- Variants of the polypeptides of the invention may occur naturally, for example, by mutation, or may be made, for example, with polypeptide engineering techniques such as site directed mutagenesis, which are well known in the art for substitution of amino acids.
- a hydrophobic residue such as glycine can be substituted for another hydrophobic residue such as alanine.
- An alanine residue may be substituted with a more hydrophobic residue such as leucine, valine or isoleucine.
- a negatively charged amino acid such as aspartic acid may be substituted for glutamic acid.
- a positively charged amino acid such as lysine may be substituted for another positively charged amino acid such as arginine.
- the invention includes polypeptides having conservative changes or substitutions in amino acid sequences. Conservative substitutions insert one or more amino acids which have similar chemical properties as the replaced amino acids.
- the invention includes sequences where conservative substitutions are made that do not destroy Na + /H + transporter activity of the transporter polypeptide.
- the preferred percentage of sequence similarity for sequences of the invention includes sequences having at least about: 48% similarity to AtNHXI , 48% similarity to AtNHX2, 56% similarity to AtNHX3, and 56% similarity to AtNHX4.
- the similarity may also be at least about: 60% similarity, 75% similarity, 80% similarity, 90% similarity, 95% similarity, 97% similarity, 98% similarity, 99% similarity, or more preferably at least about 99.5% similarity, wherein the polypeptide Na7H + has transporter activity.
- the invention also includes nucleic acid molecules encoding polypeptides, with the polypeptides having at least about: at least about: 48% similarity to AtNHXI , 48% similarity to AtNHX2, 56% similarity to AtNHX3, and 56% similarity to AtNHX4.
- the similarity may also be at least about: 60% similarity, 75% similarity, 80% similarity, 90% similarity, 95% similarity, 97% similarity, 98% similarity, 99% similarity, or more preferably at least about 99.5% similarity, wherein the polypeptide Na7H + has transporter activity, to an amino acid sequence in figure 1 or 5 (or a partial sequence thereof) considering conservative amino acid changes, wherein the polypeptide has Na7H + transporter activity.
- Sequence similarity is preferably calculated as the number of similar amino acids in a pairwise alignment expressed as a percentage of the shorter of the two sequences in the alignment.
- the reference for the clustal w program (algorithm) is Thompson, J.D., Higgins, D.G. and Gibson, T . (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice.
- Polypeptides comprising one or more d-amino acids are contemplated within the invention. Also contemplated are polypeptides where one or more amino acids are acetylated at the N-terminus.
- polypeptide mimetics with the same or similar desired biological activity (Na7H + transporter activity) as the corresponding polypeptide compound of the invention but with more favorable activity than the polypeptide with respect to solubility, stability, and/or susceptibility to hydrolysis and proteolysis. See, for example, Morgan and Gainor, Ann. Rep. Med. Chem., 24:243-252 (1989). Examples of polypeptide mimetics are described in U.S. Patent Nos. 5,643,873.
- Mimetics of the polypeptides of the invention may also be made according to other techniques known in the art. For example, by treating a polypeptide of the invention with an agent that chemically alters a side group by converting a hydrogen group to another group such as a hydroxy or amino group. Mimetics preferably include sequences that are either entirely made of amino acids or sequences that are hybrids including amino acids and modified amino acids or other organic molecules.
- the invention also includes hybrid nucleic acid molecules and polypeptides, for example where a nucleotide sequence from one species of plant is combined with a nucleotide sequence from another sequence of plant, mammal or yeast to produce a fusion polypeptide.
- the invention includes a fusion protein having at least two components, wherein a first component of the fusion protein comprises a polypeptide of the invention, preferably a full length AtNHX polypeptide.
- the second component of the fusion protein preferably comprises a tag, for example GST, an epitope tag or an enzyme.
- the fusion protein may comprise lacZ.
- the invention also includes polypeptide fragments of the polypeptides of the invention which may be used to confer salt tolerance if the fragments retain Na7H + transporter activity.
- the invention also includes polypeptides fragments of the polypeptides of the invention which may be used as a research tool to characterize the polypeptide or its activity.
- Such polypeptides preferably consist of at least 5 amino acids. In preferred embodiments, they may consist of 6 to 10, 11 to 15, 16 to 25, 26 to 50, 51 to 75,76 to 100 or 101 to 250 amino acids of the polypeptides of the invention (or longer amino acid sequences).
- the fragments preferably have sodium/proton transporter activity. Fragments may include sequences with one or more amino acids removed, for example, C-terminus amino acids in an AtNHX sequence.
- the invention also includes a composition comprising all or part of an isolated TNHX or PNHX (preferably AtNHX) nucleic acid molecule of the invention and a carrier, preferably in a composition for plant transformation.
- the invention also includes a composition comprising an isolated TNHX or PNHX polypeptide (preferably AtNHX) and a carrier, preferably for studying polypeptide activity.
- the invention also includes recombinant nucleic acid molecules comprising a nucleic acid molecule of the invention and a promoter sequence, operatively linked so that the promoter enhances transcription of the nucleic acid molecule in a host cell
- the nucleic acid molecules of the invention may be used in an isolated native gene or a chimeric gene (for example, where a nucleic acid molecule coding region is connected to one or more heterologous sequences to form a gene).
- the promoter sequence is preferably a constitutive promoter sequence or an inducible promoter sequence, operatively linked so that the promoter enhances transcription of the DNA molecule in a host cell.
- the promoter may be of a type not naturally associated with the cell.
- promoters known in the art such as the "Super-promoter” [20] or the 35S promoter of cauliflower mosaic virus [21].
- Inducible promoters are also used. These include: a) drought- and ABA-inducible promoters which may include ABA- responsive elements [22,23] b) heat shock-inducible promoters which may contain HSEs (heat shock elements) as well as CCAAT box sequences [24] c) salt-inducible promoters which may include AT and PR elements [25] d) Copper-inducible promoter that includes ACE1 binding sites [26] e) steroid-inducible promoter that includes the glucocorticoid response element along with an expression vector coding for a mammalian steroid receptor [27].
- tissue specific expression is achieved with the use of tissue-specific promoters such as, the Fd (Ferredoxin) promoter that mediates high levels of expression in green leaves [28] and peroxidase promoter for root-specific expression [29]. These promoters vary in their transcription initiation rate and/or efficiency.
- a recombinant nucleic acid molecule for conferring salt tolerance may also contain suitable transcriptional or translational regulatory elements. Suitable regulatory elements may be derived from a variety of sources, and they may be readily selected by one with ordinary skill in the art. Examples of regulatory elements include: a transcriptional promoter and enhancer or RNA polymerase binding sequence, a ribosomal binding sequence, including a translation initiation signal.
- markers may be incorporated into the recombinant molecule. Markers facilitate the selection of a transformed host cell. Such markers include genes associated with temperature sensitivity, drug resistance, or enzymes associated with phenotypic characteristics of the host organisms.
- Nucleic acid molecule expression levels are controlled with a transcription initiation region that regulates transcription of the nucleic acid molecule or nucleic acid molecule fragment of interest in a plant, bacterial or yeast cell.
- the transcription initiation region may be part of the construct or the expression vector.
- the transcription initiation domain or promoter includes an RNA polymerase binding site and an mRNA initiation site.
- Other regulatory regions that may be used include an enhancer domain and a termination region.
- the regulatory elements described above may be from animal, plant, yeast, bacterial, fungal, viral or other sources, including synthetically produced elements and mutated elements. Methods of modifying DNA and polypeptides, preparing recombinant nucleic acid molecules and vectors, transformation of cells, expression of polypeptides are known in the art.
- a plant or yeast cell is transformed with a nucleic acid molecule of the invention or a fragment of a nucleic acid molecule and inserted in a vector.
- Another embodiment of the invention relates to a method of transforming a host cell with a nucleic acid molecule of the invention or a fragment of a nucleic acid molecule, inserted in a vector.
- the invention also includes a vector comprising a nucleic acid molecule of the invention.
- the TNHX, PNHX and AtNHX nucleic acid molecules can be cloned into a variety of vectors by means that are well known in the art.
- the recombinant nucleic acid molecule may be inserted at a site in the vector created by restriction enzymes.
- a number of suitable vectors may be used, including cosmids, plasmids, bacteriophage, baculoviruses and viruses. Suitable vectors are capable of reproducing themselves and transforming a host cell.
- the invention also relates to a method of expressing polypeptides in the host cells.
- a nucleic acid molecule of the invention may be used to transform virtually any type of plant, including both monocots and dicots.
- the expression host may be any cell capable of expressing TNHX, PNHX, such as a cell selected from the group consisting of a seed (where appropriate), plant cell, bacterium, yeast, fungus, protozoa, algae, animal and animal cell.
- nucleic acid molecule expression may be controlled with nucleic acid molecules or nucleic acid molecule fragments that code for anti-sense RNA inserted in the vectors described above.
- Agrobacterium tumefaciens-mediated transformation, particle-bombardment- mediated transformation, direct uptake, microinjection, coprecipitation and electroporation-mediated nucleic acid molecule transfer are useful to transfer a Na7H + transporter nucleic acid molecule into seeds (where appropriate) or host cells, preferably plant cells, depending upon the plant species.
- the invention also includes a method for constructing a host cell capable of expressing a nucleic acid molecule of the invention, the method comprising introducing into said host cell a vector of the invention.
- the genome of the host cell may or may not also include a functional TNHX or PNHX gene.
- the invention also includes a method for expressing a TNHX or PNHX transporter polypeptide in the host cell or a plant, plant part, seed or plant cell of the invention, the method comprising culturing the host cell under conditions suitable for gene expression.
- the method preferably also includes recovering the expressed polypeptide from the culture.
- the invention includes the host cell comprising the recombinant nucleic acid molecule and vector as well as progeny of the cell.
- Preferred host cells are fungal cells, yeast cells, bacterial cells, mammalian cells, bird cells, reptile cells, amphibious cells, microorganism cells and plant cells.
- Host cells may be cultured in conventional nutrient media. The media may be modified as appropriate for inducing promoters, amplifying genes or selecting transformants.
- the culture conditions, such as temperature, composition and pH will be apparent. After transformation, transformants may be identified on the basis of a selectable phenotype. A selectable phenotype can be conferred by a selectable
- Transgenic Plants and Seeds Plant cells are useful to produce tissue cultures, seeds or whole plants.
- the invention includes a plant, plant part, seed, or progeny thereof including a host cell transformed with a PNHX nucleic acid molecule.
- the plant part is preferably a leaf, a stem, a flower, a root, a seed or a tuber.
- the invention includes a transformed (transgenic) plant having increased salt tolerance, the transformed plant containing a nucleic acid molecule sequence encoding for Na7H + transporter polypeptide activity and the nucleic acid molecule sequence having been introduced into the plant by transformation under conditions whereby the transformed plant expresses a Na7H + transporter in active form.
- the methods and reagents for producing mature plants from cells are known in the art.
- the invention includes a method of producing a genetically transformed plant which expresses PNHX or TNHX polypeptide by regenerating a genetically transformed plant from the plant cell, seed or plant part of the invention.
- the invention also includes the transgenic plant produced according to the method.
- a plant may be transformed with a vector of the invention.
- the invention also includes a method of preparing a plant with increased salt tolerance, the method comprising transforming the plant with a nucleic acid molecule which encodes a TNHX transporter polypeptide, a PNHX transporter polypeptide or a polypeptide encoding a Na7H + transporter polypeptide capable of increasing salt tolerance in a cell, and recovering the transformed plant with increased salt tolerance.
- the invention also includes a method of preparing a plant with increased salt tolerance, the method comprising transforming a plant cell with a nucleic acid molecule which encodes a TNHX transporter polypeptide, a PNHX transporter polypeptide or a polypeptide encoding a Na+/H+ transporter polypeptide capable of increasing salt tolerance in a cell, and producing the transformed plant with increased salt tolerance.
- the invention also relates to methods of producing or growing plants with increased tissue expansion (this could be manifested as enhanced size, growth or growth potential and may appear as increased or enhanced root, crown, shoot, stem, leaf, flower size or abundance in comparison to a wild type plant).
- the methods of preparing plants that have increased tissue expansion are the same as the methods for preparing a plant with increased salt tolerance described in this application (or the methods are easily adapted, to the extent that there is a difference in the methods).
- the plants whose cells may be transformed with a nucleic acid molecule of this invention and used to produce transgenic plants include, but are not limited to the following: Target plants:
- Rice Group II (transformable preferably via biolistic particle delivery systems (particle bombardment)
- the nucleic acid molecule may also be used with other plants such as oat, barley, hops, sorgum, alfalfa, sunflower, alfalfa, beet, pepper, tobacco, melon, squash, pea, cacao, hemp, coffee plants and grape vines. Trees may also be transformed with the nucleic acid molecule. Such trees include, but are not limited to maple, birch, pine, oak and poplar. Decorative flowering plants such as carnations and roses may also be transformed with the nucleic acid molecule of the invention. Plants bearing nuts such as peanuts may also be transformed with the salt tolerance nucleic acid molecule. A list of preferable plants is in Table 5.
- plant tissue cells or cultures which demonstrate salt tolerance are selected and plants which are salt tolerant are regenerated from these cultures. Methods of regeneration will be apparent to those skilled in the art (see Examples below, also). These plants may be reproduced, for example by cross pollination with a plant that is salt tolerant or a plant that is not salt tolerant. If the plants are self-pollinated, homozygous salt tolerant progeny may be identified from the seeds of these plants, for example by growing the seeds in a saline environment, using genetic markers or using an assay for salt tolerance. Seeds obtained from the mature plants resulting from these crossings may be planted, grown to sexual maturity and cross-pollinated or self-pollinated.
- the nucleic acid molecule is also incorporated in some plant species by breeding methods such as back crossing to create plants homozygous for the salt resistance nucleic acid molecule.
- a plant line homozygous for the salt tolerance nucleic acid molecule may be used as either a male or female parent in a cross with a plant line lacking the salt tolerance nucleic acid molecule to produce a hybrid plant line which is uniformly heterozygous for the nucleic acid molecule.
- Crosses between plant lines homozygous for the salt resistance nucleic acid molecule are used to generate hybrid seed homozygous for the resistance nucleic acid molecule.
- the nucleic acid molecule of the invention may also be used as a marker in transformation experiments with plants.
- a salt sensitive plant may be transformed with a salt tolerance nucleic acid molecule and a nucleic acid molecule of interest which are linked. Plants transformed with the nucleic acid molecule of interest will display improved growth in a saline environment relative to the non-transformed plants.
- fragments include 10 to 50, 50 to 100, 100 to 250, 250 to 500, 500 to 1000, 1000 to 1500, or 1500 or more nucleotides of a nucleic acid molecule of the invention.
- a fragment may be generated by removing a single nucleotide from a sequence in figure 1 or 5 (or a partial sequence thereof). Fragments may or may not have Na7H + transporter activity.
- the nucleic acid molecules of the invention can be used as probes to detect nucleic acid molecules according to techniques known in the art (for example, see US patent nos. 5,792,851 and 5,851 ,788).
- the probes may be used to detect nucleic acid molecules that encode polypeptides similar to the polypeptides of the invention. For example, a probe having at least about 10 bases will hybridize to similar sequences under stringent hybridization conditions (Sambrook et al. 1989, Molecular Cloning, A Laboratory Manual, Cold Spring Harbor).
- the invention includes oligonucleotide probes made from the AtNHX sequences described in this application or other nucleotide sequences of the invention.
- the probes may be about 10 to 30 or 15 to 30 nucleotides in length and are preferably at least 30 or more nucleotides.
- a preferred probe is 5'-TTCTTCATATATCTTTTGCCACCC-3' (coding for the amiloride binding domain) or at least about 10 or 15 nucleotides of this sequence.
- the invention also includes an oligonucleotide including at least 30 consecutive nucleotides of an AtNHX molecule in Figure 1 or 5 (or a partial sequence thereof).
- the probes are useful to identify nucleic acids encoding AtNHX, polypeptides and proteins other than those described in the application, as well as peptides, polypeptides, and proteins have Na7H + transporter activity and preferably functionally equivalent to AtNHX.
- the oligonucleotide probes are capable of hybridizing to one or more of the sequences shown in Figure 1 or 5 (or a partial sequence thereof) or the other sequences of the invention under low, moderate or high stringency hybridization conditions.
- a nucleotide sequence encoding a polypeptide of the invention may be isolated from other organisms by screening a library under low, moderate or high stringency hybridization conditions with a detectable probe (e.g. a labeled probe).
- the activity of the polypeptide encoded by the nucleotide sequence may be assessed by cloning and expression of the DNA. After the expression product is isolated, the polypeptide is assayed for Na7H + transporter activity as described in this application.
- AtNHX, TNHX or PNHX nucleic acid molecules from other cells, or equivalent AtNHX, TNHX or PNHX -encoding cDNAs or synthetic DNAs can also be isolated by amplification using Polymerase Chain Reaction (PCR) methods.
- Oligonucleotide primers, including degenerate primers, based on the amino acid sequence of the sequences in Figures 1 or 5 (or a partial sequence therof) can be prepared and used in conjunction with PCR technology employing reverse transcriptase to amplify functionally equivalent DNAs from genomic or cDNA libraries of other organisms.
- the oligonucleotides, including degenerate nucleotides can be used as probes to screen cDNA libraries.
- the invention includes an oligonucleotide probe comprising all or part of a nucleic acid in figure 1 or 5 (or a partial sequence thereof), or a complementary strand thereof.
- the probe is preferably labeled with a detectable marker.
- the invention also includes an oligonucleotide comprising at least 10, 15 or 30 nucleotides capable of specifically hybridizing with a sequence of nucleic acids of the nucleotide sequence set forth in figure 1 or 5 (or a partial sequence thereof).
- the invention also includes a single strand DNA primer for amplification of PNHX nucleic acid, wherein the primer is selected from a nucleic acid sequence derived from a nucleic acid sequence in figure 1 or 5 (or a partial sequence thereof).
- the invention also includes a method for identifying nucleic acid molecules encoding a TNHX, PNHX or AtNHX polypeptide.
- Techniques for performing the methods are described in, for example, US Patent Nos. 5,851 ,788 and 5,858,719.
- a preferred method includes contacting a sample containing nucleic acids with an oligonucleotide, wherein said contacting is effected under low, moderate or high stringency hybridization conditions, and identifying nucleic acids which hybridize thereto. Hybridization forms a hybridization complex. The presence of a complex correlates with the presence of a nucleic acid molecule encoding TNHX, plant PNHX polypeptide or AtNHX in the sample.
- the nucleic acid molecules are amplified by the polymerase chain reaction prior to hybridization.
- the invention also includes a kit for conferring increased salt tolerance to a plant or a host cell including a nucleic acid molecule of the invention (preferably in a composition fo the invention) and preferably reagents for transforming the plant or host cell.
- the invention also includes a kit for detecting the presence of a TNHX or a PNHX nucleic acid molecule, comprising at least one oligonucleotide of the invention.
- Kits may be prepared according to known techniques, for example, see patent nos. 5,851 ,788 and 5,750,653.
- the invention includes an isolated antibody immunoreactive with a polypeptide of the invention (see Example 1).
- the antibody may be labeled with a detectable marker or unlabeled.
- the antibody is preferably a monoclonal antibody or a polyclonal antibody.
- TNHX, PNHX or AtNHX antibodies can be employed to screen organisms containing TNHX, PNHX or AtNHX polypeptides. The antibodies are also valuable for immuno-purification of polypeptides from crude extracts.
- the isolated antibody is preferably specifically reactive with a TNHX or PNHX transporter, preferably an AtNHX transporter.
- the transporter is preferably encoded by a nucleic acid molecule in figure 1 (or molecules that hybridize to a molecule in figure 1 under low, moderate or high stringency hybridization conditions or molecules having at least about: 17%, at least 20%, at least 25%, or at least 35% sequence identity (or the other preferred percentages of identity or sequence similarity described above) to a molecule in figure 1 or 5 (or a partial sequence thereof).
- the transporter is preferably a polypeptide in figure 1 (or polypeptides having at least about: 28%, 35% sequence identity (or the other preferred percentages of identity or sequence similarity described above) to a polypeptide in figure 1 or 5 (or a partial sequence thereof).
- the antibody preferably does not cross-react with other transporter polypeptides.
- the antibody is preferably specifically reactive with a polypeptide having an amino acid sequence encoded by a nucleic acid molecule set forth in figure 1 or 5 (or a partial sequence thereof).
- the invention includes a method for detecting the presence of TNHX, PNHX or AtNHX transporter polypeptide, by: a) contacting a sample containing one or more polypeptides with an antibody of the invention under conditions suitable for the binding of the antibody to polypeptides with which it is specifically reactive; b) separating unbound polypeptides from the antibody; and c) detecting antibody which remains bound to one or more of the polypeptides in the sample.
- Cell cultures, seeds, plants and plant parts transformed with a nucleic acid molecule of the invention are useful as research tools.
- a plant cell or a cell line, such as an immortalized cell culture or a primary cell culture
- insert an AtNHXI nucleic acid molecule in the cell and assess the level of AtNHXI expression and activity.
- PNHX nucleic acid molecules may be overexpressed in a plant that expresses a PNHX nucleic acid molecule.
- experimental groups of plants may be transformed with vectors containing different types of PNHX nucleic acid molecules (or PNHX nucleic acid molecules similar to PNHX or fragments of PNHX nucleic acid molecules) to assess the levels of protein produced, its functionality and the phenotype of the plants (for example, phenotype in saline soil).
- the polypeptides are also useful for in vitro analysis of TNHX, PNHX or AtNHX activity or structure.
- the polypeptides produced can be used for microscopy or X-ray crystallography studies.
- the TNHX, PNHX or AtNHX nucleic acid molecules and polypeptides are also useful in assays. Assays are useful for identification and development of compounds to inhibit and/or enhance polypeptide function directly. For example, they are useful in an assay for evaluating whether test compounds are capable of acting as antagonists for PNHX polypeptides by: (a) culturing cells containing: a nucleic acid molecule which expresses PNHX polypeptides (or polypeptides having PNHX or Na+/H+ activity) wherein the culturing is carried out in the presence of: increasing concentrations of at least one test compound whose ability to inhibit transport activity of PNHX polypeptide is sought to be determined, and a fixed concentration of salt; and (b) monitoring in the cells the level of salt transported out of the cytosol as a function of the concentration of the test compound, thereby indicating the ability of the test compound to inhibit PNHX transporter activity.
- the concentration of the test compound may be fixed and the concentration of salt may be
- Another experiment is an assay for evaluating whether test compounds are capable of acting as agonists for PNHX polypeptide characterized by being able to transport salt across a membrane, (or polypeptides having PNHX or Na+/H+ transporter activity) by (a) culturing cells containing: a nucleic acid molecule which expresses PNHX polypeptide or (or polypeptides having PNHX activity) thereof, wherein said culturing is carried out in the presence of: fixed concentrations of at least one test compound whose ability to increase or enhance salt transport activity of PNHX polypeptide is sought to be determined, and an increasing concentration of salt; and (b) monitoring in the cells the level of salt transported out of the cytosol as a function of the concentration of the test compound, thereby indicating the ability of the test compound compound to increase or enhance PNHX polypeptide activity.
- the concentration of the test compound may be fixed and the concentration of salt may be increased.
- Suitable assays may be adapted from, for example, US patent no. 5,851 ,788. It is apparent that TNHX and AtNHX may also be used in assays.
- the invention includes a method for removing salt from a growth medium, comprising growing a plant transformed with a nucleic acid molecule of the invention and expressing a salt tolerance Na7H + transporter polypeptide in the growth medium for a time period sufficient for the plant root to uptake and accumulate salt in the root or shoot biomass.
- the growth medium may be a solid medium, semi- solid medium, liquid medium or a combination thereof. It may include soil, sand, sludge, compost, or artificial soil mix.
- the shoot (leaf or stem) or and root biomass may be harvested. Preferably, a sufficient portion of the shoot biomass is not harvested and is left in the growth media to permit continued plant growth.
- nucleic acid molecules of the invention may be used with other nucleic acid molecules that relate to salt tolerance, for example, osmoregulant genes. Host cells or plants may be transformed with these nucleic acid molecules. Osmoregulants are disclosed, for example, in US Patent Nos. 5,563,324 and 5,639, 950. It will be clear to those skilled in the art that sequences in figure 1 (c) and 5(a) and (b) are also useful, for example in preparation of probes or as experimental tools or as antigens to which antibodies may be directed. The following Examples are intended to illustrate and assist in the further understanding of the invention. Particular materials employed, species, conditions and the like are not intended to limit the reasonable scope of the invention. Example 1
- the invention includes methods of using such a nucleic acid molecule, for example to express a recombinant polypeptide in a transformed cell.
- the techniques described above for isolating nucleic acid molecules from Arabidopsis and sugar beet are used to isolate a salt tolerance nucleic acid molecule from Atriplex and other plants.
- Example 3 Overexpression of the PNHX transporter, preferably Arabidopsis transporter (AtNHX).
- the PNHX transporter preferably Arabidopsis transporter (AtNHX).
- the Na7H + antiport is expressed in Arabidopsis plants, although the wild type plants show impaired growth at NaCI concentrations higher than 75 mM.
- the Na7H + antiport is overexpressed in these plants in order to improve their tolerance to high salt concentrations.
- a full length cDNA (preferably coding for the AtNHXI polypeptide (AtNHX2, AtNHX3 or AtNHX4) cloned from an Arabidopsis thaliana (Columbia) seedling cDNA library is ligated into a pBINSI vector [33].
- This vector contains a constitutively strong promotor ("super-promotor' [20]).
- T-DNA vectors are used [34].
- Constructs containing the AtNHXI cDNA with the full Na7H + antiport open reading frame in a sense orientation were selected by colony hybridization using the AtNHXI as a probe and by restriction-digest analysis using Bglll restriction endonuclease. These constructs are used to transform Agrobacterium tumefaciens, and these transformed Agrobacterium tumefaciens are used for transformation of Arabidopsis plants.
- the Agrobacterium for inoculation is grown at 28°C in a medium containing 5g/l Bacto Beef Extract, 5g/l Bacto-Peptone, 1g/l Bacto Yeast Extract, 240 mg MgSO and 5g/l sucrose. The pH will be adjusted to 7.2 with NaOH.
- Arabidopsis seeds are washed and surface-sterilized in 5% (w/v) sodium hypochlorite containing 0.15% (v/v) Tween-20. The seeds are rinsed thoroughly with sterile distilled water. Seed aliquots are dispensed in flasks containing 45 ml of cocultivation medium (MS salts, 100 mM sucrose, 10 mg/l thiamine, 0.5 mg/l pyridoxine, 0.5 mg/l nicotinic acid, 100 mg/l inositol and the pH adjusted to 6.0 with KOH. The flasks are incubated at 22°C under constant rotation (190 rpm) and constant light.
- MS salts 100 mM sucrose, 10 mg/l thiamine, 0.5 mg/l pyridoxine, 0.5 mg/l nicotinic acid, 100 mg/l inositol and the pH adjusted to 6.0 with KOH.
- the flasks are incubated at
- Transformation efficiency is estimated by plating 100,000 seeds (approximately 2.5 g of seeds) on agar plates containing 50 mg/l kanamycin in a medium containing 1% (w/v) sucrose, 0.8 (w/v) agar, MS salts and a pH 6.0 adjusted with KOH.
- the plates are transferred to a growth room at 25°C under continuous light. After 10 days the kanamycin-resistant seedlings are transferred to new growth medium for 2 weeks and then transferred to small pots containing vermiculite. At senescence (8 weeks) the seeds are collected from single plants (T3). These seeds are germinated and used to assess salt tolerance of the transgenic plants.
- AtNHX3 or AtNHX4 in a number of plants (potato, tomato, brassica, cotton, sunflower, strawberries, spinach, lettuce, rice, soybean, corn, wheat, rye, barley, atriplex, salicornia, and others) is achieved by Agrobacterium tumefaciens-based transformation and/or particle bombardment (AtNHX2, AtNHX3, AtNHX4 are also useful in this example).
- Agrobacterium tumefaciens-based transformation and/or particle bombardment Agrobacterium tumefaciens-based transformation and/or particle bombardment (AtNHX2, AtNHX3, AtNHX4 are also useful in this example).
- the full length cDNA (coding for the AtNHXI) is ligated into the pBINSI vector or pBECKS (as described above) and these constructs are used to transform Agrobacterium tumefaciens strain LBA4404.
- Agrobacterium used for inoculation is grown
- Cultured cells (callus), leaf explants, shoot and root cultures are used as targets for transformation.
- the targeted tissues are co-cultivated with the bacteria for 1 - 2 days. Afterwards, the tissue is transferred to a growth media containing kanamycin. After one week the tissue is transferred to a regeneration medium containing MS salts, 1% sucrose, 2.5 mg/l 3-benzyladenine, 1 mg/l zeatin, 0.75% agar and kanamycin. Weekly transfers to fresh regeneration media are performed.
- overexpression constructs carrying the AtNHXI cDNA are introduced into an electro-competent Agrobacterium tumefaciens (LBA4404) by electroporation.
- the Agrobacteria are plated on LB plates containing 50 mg/L kanamycin and grown for ⁇ 2 days at 30°C to select for bacteria carrying the overexpression constructs.
- the Agrobacteria are then pelleted and resuspended in 1 L infiltration medium (IM - 0.5XMS salts; 0.5 g/L MES; 5% sucrose; 0.03% Silwet L-77). Flowering Arabidopsis plants with primary bolts reaching ⁇ 15cm are used for the transformation procedure (T1). Pots of Arabidopsis plants are dunked into the IM solution containing the Agrobacteria and left submerged for 2-6 minutes. The same procedure can be repeated after 8-12 days on the same plants. Plants are allowed to senesce, the plants are dried thoroughly and the seeds harvested.
- IM - 0.5XMS salts 0.5 g/L MES; 5% sucrose; 0.03% Silwet L-77.
- Seeds are plated on agar plates containing 25 mg/L kanamycin in a medium containing MS salts, 0.8% (w/v) agar adjusted to pH 6.0 with KOH. The plates are transferred to a growth room at 25 C C under continuous light. After 10 days the kanamycin-resistant seedlings (T2) are transferred to small pots containing vermiculite. At senescence ( ⁇ 8 weeks) the seeds are collected from single plants and plated on agar plates containing MS salts and 25mg/L kanamycin. After 10 days the kanamycin-resistant seedlings (T3) are transferred to small pots containing vermiculite.
- a biolistic particle delivery system particle bombardment
- NHX AtNHXI , AtNHX2, AtNHX3 or AtNHX4 are useful for this example.
- Constructs made using a plasmid vector preferably carrying a constitutive promoter, the AtNHXI open reading frame in a sense orientation and a NOS termination site are used. Plasmid DNA is precipitated into 1.25 mg of 1-2 ⁇ m gold particles using 25 ⁇ l of 2.5 M CaCI 2 and 10 ⁇ l of 0.1 M thiamine (free base).
- DNA-coated particles are washed with 125 ⁇ l of 100% ethanol and then resuspended in 30 ⁇ l ethanol. The samples are sonicated to obtain an efficient dispersion, and the samples are aliquoted to obtain delivery disks containing 3 ⁇ g of DNA each.
- Particle bombardment is optimized according to the specific tissue to be transformed. Tissue samples are placed in Petri dishes containing 4.5 g/l basal MS salts, 1 mg/l thiamine, 10 mg/l myoinositol, 30 g/l sucrose, 2.5 mg/l amphotericin and 10 mM K 2 HPO 4 at pH 5.7. After bombardment the petri dishes are incubated for 18 - 24 hours.
- Tissue is regenerated in plates with growth media containing the selective marker. Rooting is initiated and transformed plants are grown under optimal growth conditions in growth chambers. After 2 - 4 weeks the seedlings are transferred to new growth medium for 2 weeks and then transferred to small pots containing vermiculite. At senescence the seeds are collected from single plants. These seeds are germinated and used to assess salt tolerance of the transgenic plants.
- AtNHXI -homologs from other plant species preferably salt tolerant species (i.e., sugar beet) in other plants (potato, tomato, brassica, cotton, sunflower, strawberries, spinach, lettuce, rice, soybean, corn, wheat, rye, barley, atriplex, salicornia, and others) is achieved by Agrobacterium tumefaciens-based transformation and/or particle bombardment as described above (in Examples 3 and 4). Regeneration of the transformed plants is performed as described in Examples 3 and 4 (AtNHX2, AtNHX3 or AtNHX4).
- salt tolerant species i.e., sugar beet
- Agrobacterium tumefaciens-based transformation and/or particle bombardment as described above (in Examples 3 and 4). Regeneration of the transformed plants is performed as described in Examples 3 and 4 (AtNHX2, AtNHX3 or AtNHX4).
- TNHX or PNHX preferably AtNHXI , AtNHXI homologs (such as AtNHX2, AtNHX3, AtNHX4), and AtNHXI derivatives in yeast is useful to assess and characterize the biochemical properties of the recombinant and native polypeptides. Expression in yeast also facilitates the study of interactions between AtNHXI , its homologs and derivatives with regulatory polypeptides.
- conditional expression constructs by ligating the coding region of the AtNHXI cDNA into two vectors, pYES2 (Invitrogen) and pYEP434 [35].
- oligonucleotide PCR primers based upon highly conserved regions within Na7H + exchangers (one within the amiloride-binding domain, and another within a region about 200 amino acid residues further downstream) from Arabidopsis, yeast, mammals, and C. elegans, to generate a 600 - 1,000 bp DNA fragments by PCR.
- sequence-specific oligonucleotides with 5' BamHI (sense strand) and 3' EcoRI (antisense strand) flanking restriction sites, were used for PCR-mediated amplification of the unique (partial) coding regions from each isoform, and the digested PCR products were ligated into EcoRI/BamHI-digested pGEX2TK vector.
- pGEX2TK plasmids containing the inserts corresponding to each AtNHX isoform were sequenced on both strands to verify the fidelity of the PCR reaction and were used for expression and purification of the recombinant GST-fusion proteins in E.coli (BL21 pLysS) as per manufacturers instructions (Pharmacia).
- Example 8 Biochemical characterization and functional analysis of Na * /H * exchangers from Arabidopsis and other plants, preferably salt-tolerant (halophytes) plants.
- Biochemical characterization of the Na + /H + exchanger isoforms is performed in (i) heterologous eukaryotic expression systems (baculovirus expression system in Sf9 insect cells, transgenic yeast); and in (ii) transgenic plants.
- heterologous expression systems allows the fast characterization of the kinetic properties of each exchanger isoform (K m , V max , ion specificity).
- Baculovirus- infected Sf9 cells have proven to be a useful and adaptable system for high-level expression of correctly folded eukaryotic membrane proteins, thus they are an ideal tool for the study of membrane-bound proteins.
- the large size of the cells, combined with the relatively short time needed for the expression of the foreign plasma membrane- bound proteins (3-4 days) provides an excellent experimental system for the application of isotope exchange techniques.
- the Invitrogen baculovirus Sf9 insect cell system is used for expression in Sf9 insect cells.
- Expression vector constructs (pBluBac4.5, invitrogen) encoding full-length AtNHX exchanger proteins are prepared for each AtNHX and other PNHX isoforms using a PCR-based subcloning approach similar to that described above for the generation of GST-fusion proteins. Initially, the suitability of the insect cell expression system for uptake analysis is performed using a single AtNHX isoform. The other PNHX isoforms are studied in a similar manner.
- Yeast (strain w303a) have been transformed with this construct and expression of the recombinant plant protein is confirmed once the antiserum is available.
- salt-tolerance of transformed yeast isassessed for each AtNHX isoform by comparing growth rates at different NaCI concentrations.
- Methods for the isolation of transport-competent plasma membranes and tonoplast and the isolation of intact vacuoles are performed.
- the kinetics of H + /Na + exchange is measured in intact insect cells and yeast, intact yeast vacuoles, and isolated plasma membranes and tonoplast vesicles according to known methods.
- Na + influx in intact cells is monitored by isotopic exchange using [ 22 Na + ]CI and fast-filtration techniques [17,i,ii].
- Kinetics of H + - dependent Na + fluxes in vesicles is monitored by following the pH-dependent fluorescent quench of acridine dyes [13,17].
- Heterologous expression of plant transport molecules in Saccharomyces cerevisiae has been used successfully in recent years in numerous studies.
- the availability of yeast mutants with salt-sensitive phenotypes (generated by 'knock-outs' of sodium transport molecules such as ⁇ ena1-4 - the plasma membrane Na + - ATPase pumps) makes it an especially suitable system for the study of sodium transport molecules.
- This heterologous expression facilitates kinetic studies of the antiport activity in yeast cells using radiolabelled 22 Na + .
- Mutant yeast cells having a suppressed phenotype as a result of the expression of a plant Na + /H + antiport are transformed with an Arabidopsis cDNA library for the purpose of identifying particular regulators of these antiport molecules.
- a phenotype of increased sodium tolerance in yeast identifies particular positive regulators of the antiport activity while negative regulators are identified by a phenotype of decreased sodium tolerance.
- Arabidopsis represents a readily transformable model organism with the particular advantage of having a short generation time.
- Agrobacterium tumefaciens- mediated genetic transformation is utilized for Arabidopsis (ecotype Columbia). Studies include the overexpression of PNHX transgenes in a wild-type background, combined overexpression of more than one PNHX transgene, and suppression of endogenous PNHX expression using antisense PNHX expression. Stable transformation of progeny is confirmed by Southern blotting.
- transgenes Overexpression of transgenes, or suppression of expression using antisense constructs, is confirmed by Northern and western blotting.
- salt-tolerance of transgenic plants is compared to wild-type plants, and control plants transformed with empty transformation vectors. Separate transformations are performed on Arabidopsis plants using expression vector constructs for each of the different AtNHX isoforms.
- Arabidopsis plants are transformed with PNHX genes from other plants, preferably salt tolerant plants in order to assess the effect on salt tolerance of the expression of a Na7H + exchanger in a glycophytic plant.
- AtNHXI , AtNHX2, AtNHX3 and AtNHX4 cDNAs are subcloned in a sense orientation into the expression vector containing a "superpromoter" [20].
- a PCR based subcloning strategy is used for each AtNHX cDNA as described above for the production of NHXGST-fusion constructs.
- oligonucleotides with Sail and Sad restriction sites flanking the C-terminal and N- terminal PNHX regions respectively are used for PCR amplification.
- All plasmid constructs are sequenced on both strands to confirm the fidelity of the PCR amplification before transformation of Agrobacterium tumefaciens (strain LBA4404).
- Agrobacterium tumefaciens strain LBA4404.
- For each PNHX- pBISNI construct approximately 1L of Agrobacterium culture, grown under antibiotic selection at 28°C, is used for the transformation of Arabidopsis. Plants are ready for transformation when primary bolts are approximately 15cm. About 2 flats of plants ( ⁇ 80 plants per flat) are used per transformation. A highly efficient, vacuum-less infiltration transformation method [iii] is used.
- Agrobacterium cultures are resuspended in an infiltration media containing a mild surfactant (Silwet L-77, Lehle Seeds), and each pot of Arabidopsis is simply submerged in the Agrobacterium for 2-6 minutes. Plants are thereafter drained, and returned to the growth chamber until the seeds are ready for harvesting (about 4 weeks). Seeds (T1 generation) are collected and after surface sterilization, are plated on sterile, selective media containing kanamycin, vernalized, and then grown under optimal conditions. Healthy seedlings showing kanamycin resistence after about 7 days are transplanted to soil and the presence of the transgene confirmed by Southern blotting.
- a mild surfactant Sudwet L-77, Lehle Seeds
- T1 transformants ie T2 generation
- T2 plants used for Northern and western blotting to determine the expression patterns of the transgenes and PNHX proteins.
- Representative transgenic lines e.g. showing low, medium, or high transgene expression
- a similar approach is used for transformation of Arabidopsis with the PNHXs from other plants.
- Salt tolerance is assessed by measuring the growth rate of the plants at increasing salt concentrations. Plant biomass, root/shoot ratios, tissue ion content is measured. Root and hypocotyl growth rates is measured and correlated with tissue water content of plants growing at different NaCI concentrations. Example 11
- cotlyedons are excised and imbedded into Murashige-Skoog medium (Gibco) enriched with benyzladenine.
- Expression vector constructs are prepared using a PCR-based subcloning approach as described above using the pCGN5059 binary plasmid (which employs the CaMV 35S promoter to drive constitutively high expression) engineered for gentamycin resistance [iv] and cDNAs of the various AtNHX clones and/or the halophyte PNHX clones, and the choosen plant PNHX clones.
- Excised cotyledons are infected with Agrobacterium cultures (strain EHA101), containing the vector construct of interest, by brief dipping and then co-cultivated with the Agrobacterium for a 72h. Subsequently, cotlyedons are transferred to regeneration medium containing gentamycin as the selective agent. After explant regeneration, and subculturing, on selective media ( ⁇ 4 weeks) explants are transferred to rooting medium and then into soil once a root mass has developed. Tissue samples are examined from growing plants to confirm transgene presence by Southern blotting as described above for the transformation of Arabidopsis.
- Transformed plants (T1 generation) are allowed to flower and set seed and these seeds are germinated (T2) under selective conditions and transformants used for expression analysis of the transgenes and evaluation of salt-tolerance as described above. Also, biochemical analysis of the plants is performed. These include, Na + /K + ratios, sugar, amino acid and quaternary N-compounds. Salt-tolerance is also evaluated in fields trials. b) Microprojectile bombardment-mediated transformation of crop plants.
- a microprojectile bombardment-mediated transformation of crop plants is used when Agrobacterium tumefaciens-mediated transformation is not successful.
- Expression vector constructs, using the pBAR vector for high level expression of AtNHX or the halophyte PNHX or the endogenous PNHX from the plant of choice, are used in conjunction with the microprojectile bombardment system as described by Tomes et al. [v]. Bombardment procedures is carried out in callus tissue.
- Plant calli are initiated by culturing immature embryos on Callus medium [vi]. After about 2 weeks, friable calli that are growing rapidly are subcultured and grown for an additional 2 weeks and then used for transformation. Calli for transformation are transferred to fresh medium, incubated for 24 h and bombarded with tungsten microprojectiles carrying the pBARNHX vector construct. Bombardment conditions is performed according to manufacturer's instructions. Calli that show visible growth 10 days after bombardment are transferred to selective media (containing either Bialaphos or Ignite) in order to identify putative transformants. The growth of transformed plant calli on this selective media is continued for 3-4 months. Each putative stable transgenic event becomes apparent as a mass of friable embyogenic callus growing in the presence of the selection agent.
- selective media containing either Bialaphos or Ignite
- Stable transformation is verified by Southern blots. Selected calli are transferred onto a regeneration medium [v], kept in the dark at 28°C for 7 days and then transferred to growth chambers under a 16-h photoperiod until green shoots appear. Plantlets (1-2 cm long) are transferred to individual tubes containing germination medium to allow continued development. At the three to four leaf stage, plants are transferred to soil and into the greenhouse. At the eight-leaf stage, these plants are sprayed with 1% (w/v) Ignite herbicide to detect the presence of the BAR gene. This herbicide kills those plants not carrying the BAR gene. Confirmed transgenic plants (T1) are allowed to mature, flower, set seed, and seeds used for the production of T2 plants. Transgenic T2 plants are used for the evaluation of salt- tolerance as described above. Transgenic T2 and T3 plants are used in field trials for the evaluation of salt tolerance.
- the full-length cDNA of AtNHXI was cloned by us from an Arabidopisis thaliana (Columbia) seedling cDNA library [38].
- the library was initially screened with an EST (GenBank # T75860; Figure 8(h)) obtained from the Arabidopsis Biological Resource Center (ABRC) that showed homology to Arabidopsis genomic sequence (A- TM021 B04.4).
- the invention includes nucleic acid molecules of between about: 500- 1000, 1000-1500 1500-1600, 1600-1700, 1700-2000 or 2000-2500 or greater than 2500 nucleotides including the EST sequence (or a sequence having at least about: 35, 35, 55, 65, 75, 85, 90, 95, 99, 99.5 sequence identity to the EST sequence or the polypeptide encoded by the EST sequence) and which encodes a polypeptide that extrudes monovalent (preferably potassium ions or lithium ions, most preferably sodium ions) out of the cytosol for preparation of transgenic plants and host cells, and in the other methods of the invention described below.
- EST sequence or a sequence having at least about: 35, 35, 55, 65, 75, 85, 90, 95, 99, 99.5 sequence identity to the EST sequence or the polypeptide encoded by the EST sequence
- the Arabidopsis genomic sequence predicted a polypeptide of 457 amino acids. Plaques that hybridized with the labeled EST probe were subjected to a secondary screen using the PCR product from the nested amplification of a region coding for the N-terminal portion of the predicted polypeptide.
- the forward primer based on the predicted start codon of the polypeptide (Primer-NT), 5- GCCATGTTGGATTCTCTAGTGTCG-3 and the reverse primer, based on the stop codon predicted from the EST (Primer-CT), 5'-
- CCGAATTCTCAAAGCTTTTCTTCCACG-3' were used to amplify a 1.7 kb product from the seedling library.
- This product was purified by agarose gel electrophoresis and used as the template for a second amplification using primer-NT and a reverse primer (primer-C) based on the genomic sequence, 5'- CGGAATTCACAGAAAAACACAGTGAGGAT-3'.
- primer-C reverse primer
- the resulting 900 bp fragment served as the template for the probe used in the secondary screen.
- the pure plaques obtained in the secondary screen were tested by PCR using the primer-NT, primer-CT combination. Three of the plaques, from which a 1.7 kb product was amplified, were selected for excision of the phagemid.
- AtNHX2 cDNA was cloned from an Arabidopsis thaliana (Columbia) seedling cDNA library.
- PCR primers were designed for the amplification of the AtNHX2 sequence based on a BAC DNA sequence (MTE17) with a predicted amino acid sequence showing homology to AtNHXI .
- GATCCAATGTAACACCGGAG-3 were used to amplify a 1.2 kb product from the seedling library by PCR. This product was purified by agarose gel electrophoresis and used as a probe in hybridization screening of the seedling cDNA library. Plaques that hybridized with the iabeled probe were subjected to a secondary screen using the 1.2 kb PCR product as a probe. Pure plaques obtained in the secondary screen were tested by PCR using primer - X6F, primer - X6REV combination. Only one of the plaques had the 1.2 kb product amplified from it. This plaque was used for excision of the phagemid. This clone was used for complete sequencing.
- AtNHX3 and AtNHX4 Na + /H + antiport cDNAs Full length AtNHX3 and AtNHX4 cDNAs were cloned by us from an Arabidopsis thaliana (Columbia) seedling cDNA libraries (CD4-15 and CD4-16; Arabidopsis Stock Center, Columbus, Ohio). PCR primers were designed for the amplification of a genomic sequence based on a BAC DNA sequence (F20D21) with a predicted amino acid sequence showing homology to both AtNHXI and AtNHX2.
- the forward primer (NHX7F), 5-TTCGTTCTCGGCCATGTCC-3 ' and the reverse primer (NHX7REV), 5- CGGAGAGACCAACACCTTCTGC-3 ' were used to amplify a 2.2 kb product using Arabidopsis thaliana (Columbia) genomic DNA as a template.
- This product was purified by agarose gel electrophoresis and used as a probe in hybridization screening of the seedling cDNA libraries. Plaques that hybridized with the labeled probe were subjected to a secondary screen using the 2.2 kb PCR product as a probe.
- Genomic DNA was isolated from mature leaf tissue of Arabidopsis thaliana (Columbia). 10 ug of this genomic DNA was digested with Gal, EcoR1 , Xbal, or Hindlll, fractionated on 0.7% agarose gel, and transferred to Hybond N + membrane (Amersham) according to manufacturers instructions. Overnight hybridization was performed at 65°C in Amersham hybridization buffer with AtNHXI cDNA fragments labeled with 32 P by the random priming method. The final wash was in 0.1 X SSPE, 0.1% SDS at 65°C. Hybridization signals were detected by autoradiography on BioMax hyperfilm (Kodak).
- An AtNHXI PCR product was amplified using Vent DNA polymerase (New England Biolabs) with the following primers (SE-ATX1-Sall 5'- CGCGTCGACATGTTGGATTCTCTAGTGTCG-3' and ATXCT2 5'- CCGAATTCTCAAAGCTTTTCTTCCACG-3').
- This product was digested with Sail gel purified and used in a ligation reaction along with pBISNI prevously digested with Sail and Smal and gel purified.
- the resulting vector pBISNI-AtNHXI contained the AtNHXI open reading frame in a sense orientation under the control of the super promoter.
- Overexpression constructs carrying the AtNHXI cDNA are introduced into an electro-competent Agrobacterium tumefaciens (LBA4404) by electroporation.
- the Agrobacteria are plated on LB plates containing 50 mg/L kanamycin and grown for ⁇ 2 days at 30 °C to select for bacteria carrying the overexpression constructs.
- One liter liquid LB+kanamycin (50mg/L) is inoculated with a single Agrobacterium colony selected from the LB (kanamycin 50mg/L) plates.
- the Agrobacteria are then pelleted and resuspended in 1 L infiltration medium (IM - 0.5XMS salts; 0.5 g/L MES; 5% sucrose; 0.03% Silwet L-77). Flowering Arabidopsis plants with primary bolts reaching ⁇ 15cm are used for the transformation procedure (T1). Pots of Arabidopsis plants are dunked into the IM solution containing the Agrobacteria and left submerged for 2-6 minutes. The same procedure can be repeated after 8-12 days on the same plants. Plants are allowed to senesce, the plants are dried thoroughly and the seeds harvested.
- IM - 0.5XMS salts 0.5 g/L MES; 5% sucrose; 0.03% Silwet L-77.
- Seeds are plated on agar plates containing 25 mg/L kanamycin in a medium containing MS salts, 0.8% (w/v) agar adjusted to pH 6.0 with KOH. The plates are transferred to a growth room at 25 °C under continuous light. After 10 days the kanamycin-resistant seedlings (T2) are transferred to small pots containing vermiculite. At senescence ( ⁇ 8 weeks) the seeds are collected from single plants and plated on agar plates containing MS salts and 25mg/L kanamycin. After 10 days the kanamycin-resistant seedlings (T3) are transferred to small pots containing vermiculite. Seeds produced by these plants are germinated and used to assess salt tolerance of the transgenic plants.
- SSC sodium chloride-sodium citrate buffer
- SSDNA single stranded DNA Table 5 - List of Plants
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Botany (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU28214/99A AU2821499A (en) | 1998-03-18 | 1999-03-18 | Genetic engineering salt tolerance in crop plants |
CA2323756A CA2323756C (en) | 1998-03-18 | 1999-03-18 | Genetic engineering salt tolerance in crop plants |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7847498P | 1998-03-18 | 1998-03-18 | |
US60/078,474 | 1998-03-18 | ||
US11611199P | 1999-01-15 | 1999-01-15 | |
US60/116,111 | 1999-01-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999047679A2 true WO1999047679A2 (en) | 1999-09-23 |
WO1999047679A3 WO1999047679A3 (en) | 1999-11-25 |
Family
ID=26760573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA1999/000219 WO1999047679A2 (en) | 1998-03-18 | 1999-03-18 | Genetic engineering salt tolerance in crop plants |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2821499A (en) |
CA (1) | CA2323756C (en) |
WO (1) | WO1999047679A2 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000037644A1 (en) | 1998-12-22 | 2000-06-29 | National Institute Of Agrobiological Sciences | Sodium/proton countertransporter gene |
EP1123977A1 (en) * | 1999-08-24 | 2001-08-16 | Suntory Limited | GENES ENCODING PROTEINS REGULATING pH OF VACUOLES |
WO2002016423A2 (en) * | 2000-08-25 | 2002-02-28 | Basf Plant Science Gmbh | PLANT POLYNUCLEOTIDES ENCODING NOVEL Na+/H+ ANTIPORTERS |
EP1231831A1 (en) * | 1999-11-10 | 2002-08-21 | University of Connecticut | Stress-resistant oversized transgenic plants capable of growing in salinized soil |
EP1315795A1 (en) * | 2000-08-18 | 2003-06-04 | The University of Connecticut | Methods for imparting desirable phenotypic traits, including drought, freeze, and high salt tolerance and methods for increasing seed production |
EP1315410A1 (en) * | 2000-08-18 | 2003-06-04 | The University of Connecticut | Enhanced meristematic activity and competence by overexpression of tonoplast pyrophosphatase |
WO2004007668A2 (en) * | 2002-07-12 | 2004-01-22 | The Regents Of The University Of California | Improved transporters and their uses |
US7244878B2 (en) | 1998-03-18 | 2007-07-17 | Eduardo Blumwald | Increasing salt tolerance in plants by overexpression of vacuolar Na+ /H+ transporters |
US7256326B2 (en) | 1998-03-18 | 2007-08-14 | Eduardo Blumwald | Genetic engineering salt tolerance in crop plants |
EP1970442A1 (en) | 2002-05-03 | 2008-09-17 | Monsanto Technology LLP | Transgenic high tryptophan plants |
US7442852B2 (en) | 1998-03-18 | 2008-10-28 | Eduardo Blumwald | High salt plants and uses for bioremediation |
US8058515B2 (en) | 1999-11-10 | 2011-11-15 | University Of Connecticut | Plant cells and plants overexpressing vacuolar proton pyrophosphatases |
US8697950B2 (en) | 1999-11-10 | 2014-04-15 | University Of Connecticut | Vacuolar pyrophosphatases and uses in plants |
US8715964B2 (en) | 2008-05-11 | 2014-05-06 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Expression of IL-12 family heterodimers |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2336173B2 (en) | 2007-10-24 | 2011-01-24 | Universidad Politecnica De Valencia | METHOD TO IMPROVE THE TOLERANCE TO SALINITY. |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991006651A1 (en) * | 1989-10-31 | 1991-05-16 | Queen's University At Kingston | Gene conferring salt tolerance |
-
1999
- 1999-03-18 CA CA2323756A patent/CA2323756C/en not_active Expired - Lifetime
- 1999-03-18 AU AU28214/99A patent/AU2821499A/en not_active Abandoned
- 1999-03-18 WO PCT/CA1999/000219 patent/WO1999047679A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991006651A1 (en) * | 1989-10-31 | 1991-05-16 | Queen's University At Kingston | Gene conferring salt tolerance |
Non-Patent Citations (11)
Title |
---|
APSE, MARIS P. ET AL: "Salt tolerance conferred by overexpression of a vacuolar Na+/H+ antiport in Arabidopsis" SCIENCE (WASHINGTON, D. C.) (1999), 285(5431), 1256-1258 , XP002117186 * |
BARKLA, BRONWYN J. ET AL: "The plant vacuolar Na+/H+ antiport" SYMP. SOC. EXP. BIOL. (1994), VOLUME DATE 1993, 48, 141-53 , XP002117177 * |
BARKLA, BROWYN J. (1) ET AL: "Tonoplast Na+/H+ antiport activity and its energization by the vacuolar H+-ATPase in the halophytic plant Mesembryanthemum crystallinum L." PLANT PHYSIOLOGY (ROCKVILLE), (1995) VOL. 109, NO. 2, PP. 549-556. , XP002117182 * |
BOHNERT H J ET AL: "Strategies for engineering water-stress tolerance in plants" TRENDS IN BIOTECHNOLOGY, vol. 14, no. 3, 1 March 1996 (1996-03-01), page 89-97 XP004035825 ISSN: 0167-7799 * |
BORGESE F. ET AL.: "Cloning and expression of a cAMP-activated Na+/H+ exchanger: evidence that the cytoplasmic domain mediates hormonal regulation" PNAS,U.S.A., vol. 89, 1992, pages 6765-6769, XP002117180 * |
DANTE M. ET AL.: "AC O04655" EMBL DATABASE,1 July 1997 (1997-07-01), XP002117178 Heidelberg * |
GAXIOLA R A ET AL: "The Arabidopsis thaliana proton transporters, AtNhx1 and Avp1, can function in cation detoxification in yeast." PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (1999 FEB 16) 96 (4) 1480-5. , XP002117185 * |
NEWMAN T. ET AL.: "AC T75860" EMBL DATABASE,25 March 1995 (1995-03-25), XP002117179 Heidelberg * |
OHKI R. ET AL.: "AC D49589" EMBL DATABASE,22 March 1995 (1995-03-22), XP002117181 Heidelberg * |
RAUSCH, THOMAS ET AL: "Salt stress responses of higher plants: The role of proton pumps and Na+/H+-antiporters." JOURNAL OF PLANT PHYSIOLOGY, (1996) VOL. 148, NO. 3-4, PP. 425-433. , XP002117184 * |
SCHACHTMAN D. ET AL.: "Molecular and functional characterization of a novel low-affinity cation transporter (LCT1) in higher plants" PNAS,U.S.A., vol. 94, September 1997 (1997-09), pages 11079-11084, XP002117183 * |
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7244878B2 (en) | 1998-03-18 | 2007-07-17 | Eduardo Blumwald | Increasing salt tolerance in plants by overexpression of vacuolar Na+ /H+ transporters |
US7442852B2 (en) | 1998-03-18 | 2008-10-28 | Eduardo Blumwald | High salt plants and uses for bioremediation |
US7256326B2 (en) | 1998-03-18 | 2007-08-14 | Eduardo Blumwald | Genetic engineering salt tolerance in crop plants |
US7250560B2 (en) | 1998-03-18 | 2007-07-31 | Eduardo Blumwald | Increasing salt tolerance in plants by overexpression of vacuolar NA+/H+ transporters |
US6861574B2 (en) | 1998-12-22 | 2005-03-01 | National Institute Of Agrobiological Sciences | Sodium/proton antiporter gene |
WO2000037644A1 (en) | 1998-12-22 | 2000-06-29 | National Institute Of Agrobiological Sciences | Sodium/proton countertransporter gene |
US7326827B2 (en) | 1998-12-22 | 2008-02-05 | National Institute Of Agrobiological Sciences | Sodium/proton antiporter gene |
EP1123977A4 (en) * | 1999-08-24 | 2005-09-21 | Suntory Ltd | GENES ENCODING PROTEINS REGULATING pH OF VACUOLES |
EP1123977A1 (en) * | 1999-08-24 | 2001-08-16 | Suntory Limited | GENES ENCODING PROTEINS REGULATING pH OF VACUOLES |
EP1231831A1 (en) * | 1999-11-10 | 2002-08-21 | University of Connecticut | Stress-resistant oversized transgenic plants capable of growing in salinized soil |
EP1231831A4 (en) * | 1999-11-10 | 2004-06-30 | Univ Connecticut | Stress-resistant oversized transgenic plants capable of growing in salinized soil |
US8697950B2 (en) | 1999-11-10 | 2014-04-15 | University Of Connecticut | Vacuolar pyrophosphatases and uses in plants |
US8058515B2 (en) | 1999-11-10 | 2011-11-15 | University Of Connecticut | Plant cells and plants overexpressing vacuolar proton pyrophosphatases |
US8003852B2 (en) | 1999-11-10 | 2011-08-23 | University Of Connecticut | Transgenic plants overexpressing a plant vacuolar pyrophosphatase |
EP1315795A1 (en) * | 2000-08-18 | 2003-06-04 | The University of Connecticut | Methods for imparting desirable phenotypic traits, including drought, freeze, and high salt tolerance and methods for increasing seed production |
EP1315410A1 (en) * | 2000-08-18 | 2003-06-04 | The University of Connecticut | Enhanced meristematic activity and competence by overexpression of tonoplast pyrophosphatase |
EP1315795A4 (en) * | 2000-08-18 | 2004-06-23 | Univ Connecticut | Methods for imparting desirable phenotypic traits, including drought, freeze, and high salt tolerance and methods for increasing seed production |
US8168864B2 (en) | 2000-08-18 | 2012-05-01 | Beth Israel Deaconess Medical Center | Transgenic pollen expressing exogenous plant vacuolar pyrophosphatase and methods for increasing seed production in plants |
EP1315410A4 (en) * | 2000-08-18 | 2004-06-23 | Univ Connecticut | Enhanced meristematic activity and competence by overexpression of tonoplast pyrophosphatase |
US7186561B2 (en) | 2000-08-25 | 2007-03-06 | Basf Plant Science Gmbh | Plant polynucleotides encoding novel Na+/H+ antiporters |
AU2001288404B2 (en) * | 2000-08-25 | 2006-08-03 | Basf Plant Science Gmbh | Plant polynucleotides encoding novel Na+/H+ antiporters |
WO2002016423A2 (en) * | 2000-08-25 | 2002-02-28 | Basf Plant Science Gmbh | PLANT POLYNUCLEOTIDES ENCODING NOVEL Na+/H+ ANTIPORTERS |
WO2002016423A3 (en) * | 2000-08-25 | 2003-06-26 | Basf Plant Science Gmbh | PLANT POLYNUCLEOTIDES ENCODING NOVEL Na+/H+ ANTIPORTERS |
EP1970442A1 (en) | 2002-05-03 | 2008-09-17 | Monsanto Technology LLP | Transgenic high tryptophan plants |
WO2004007668A2 (en) * | 2002-07-12 | 2004-01-22 | The Regents Of The University Of California | Improved transporters and their uses |
AU2003248923B2 (en) * | 2002-07-12 | 2008-09-25 | The Regents Of The University Of California | Improved transporters and their uses |
WO2004007668A3 (en) * | 2002-07-12 | 2004-07-29 | Univ California | Improved transporters and their uses |
US8715964B2 (en) | 2008-05-11 | 2014-05-06 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Expression of IL-12 family heterodimers |
US9546202B2 (en) | 2008-05-11 | 2017-01-17 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Expression of IL-12 family heterodimers |
Also Published As
Publication number | Publication date |
---|---|
CA2323756C (en) | 2010-09-21 |
WO1999047679A3 (en) | 1999-11-25 |
CA2323756A1 (en) | 1999-09-23 |
AU2821499A (en) | 1999-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7256326B2 (en) | Genetic engineering salt tolerance in crop plants | |
US7244878B2 (en) | Increasing salt tolerance in plants by overexpression of vacuolar Na+ /H+ transporters | |
EP1681349B1 (en) | Genetic control of plant growth and development | |
KR101372114B1 (en) | Rice zinc finger protein transcription factor DST and use thereof for regulating drought and salt tolerance | |
US9809827B2 (en) | Transgenic maize | |
US8003852B2 (en) | Transgenic plants overexpressing a plant vacuolar pyrophosphatase | |
Lopez et al. | Accumulation of a 22‐kDa protein and its mRNA in the leaves of Raphanus sativus in response to salt stress or water deficit | |
CA2323756C (en) | Genetic engineering salt tolerance in crop plants | |
AU2005336142A1 (en) | A transgenic plant having enhanced drought tolerance | |
US20160068860A1 (en) | Transgenic plants | |
CA2390719A1 (en) | Method of transforming plants with vacuolar pyrophosphatase and stress-resistant oversized plants produced by the method | |
CN106471124B (en) | Tonoplast proton/sugar antiporter and its use to increase sucrose concentration in plant sucrose storage organs | |
US20110099650A1 (en) | Compositions and method for modulating plant root hair development | |
KR20010104316A (en) | Sodium/proton countertransporter gene | |
WO2009020528A1 (en) | Vacuolar pyrophosphatases and uses in plants | |
BRPI0718321A2 (en) | GIF1 HARVEST GRAIN FILLING GENE AND THE SAME APPLICATIONS. | |
US7442852B2 (en) | High salt plants and uses for bioremediation | |
KR20110085729A (en) | Ostmt1 gene involved in vacuolar sugar transport from rice | |
CA2258694A1 (en) | G protein signal transduction in plants | |
WO1998004701A1 (en) | Methods and compositions for improving a plant's ability to take in phosphate from soil | |
WO2006013807A1 (en) | Arabinogalactan protein having activity of improving tolerance to heat or moisture stress | |
CA2313449A1 (en) | Engineering salt tolerance in crop plants | |
CN112501184B (en) | Soybean GmMT1 gene, vector containing GmMT1 gene, and preparation method and application thereof | |
KR20110085732A (en) | Ostmt2 gene involved in vacuolar sugar transport from rice | |
JP2004500091A (en) | Modification and adaptation of growth under hypoxic conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Kind code of ref document: A Ref document number: 2323756 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |